Skip to main content

Overview of Structural Interventions to Decrease Injection Drug-Use Risk

  • Chapter
  • First Online:
Best Evidence Structural Interventions for HIV Prevention

Abstract

Injection drug equipment sharing continues to contribute dramatically to the worldwide spread of human immunodeficiency virus (HIV) and other blood-borne pathogens among injection drug users (IDUs). After acquiring a blood-borne infection through contaminated injection paraphernalia, IDUs may then pass it to their drug sharing and sexual partners as well as their future offspring (Taussig, Weinstein, Burris, & Jones, 2000). HIV often spreads rapidly among IDUs, in part because very few health and social services are available to them. Internationally, as many as 92% of IDUs in low- and middle-income countries have no access to any type of HIV prevention (Fiellin, Green, & Heimer, 2008). Furthermore, on average IDUs engage in less safe sex practices than the general population, possibly due to decreased judgment when under the influence and/or unsafe sex in exchange for money or drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Academy for Educational Development (2002). Physician prescription of sterile syringes to injection drug users. Centers for Disease Control. Retrieved February 1, 2011, from http://www.hawaii.edu/hivandaids/Physician%20Prescription%20of%20Sterile%20Syringes%20to%20Injection%20Drug%20Users.pdf

  • Brady, J. E., Friedman, S. R., Cooper, H. L. F., Flom, P. L., Tempalski, B., & Gostnell, K. (2008). Estimating the prevalence of injection drug users in the U.S. and in Large U.S. metropolitan areas from 1992 to 2002. Journal of Urban Health, 85(3), 323–351.

    Article  PubMed  Google Scholar 

  • Burris, S. T. (2010). Syringe access interventions. Retrieved December 16, 2011, from http://knol.google.com/k/saprp-knowledgeassets/syringe-access-interventions/13kykpwd3qs47/20

  • Centers for Disease Control and Prevention (2002). Drug-associated HIV transmission continues in the United States. Retrieved January 1, 2012, from http://www.cdc.gov/hiv/resources/factsheets/idu.htm

  • Centers for Disease Control and Prevention (2005). New attitudes & strategies: A comprehensive approach to preventing blood-borne infections among IDUs, archival content 1999–2005. IDU HIV Prevention. Retrieved January 24, 2012, from http://www.cdc.gov/idu/idu.htm

  • Centers for Disease Control and Prevention (2006). Estimates of new HIV infections in the United States. Retrieved January 30, 2012, from http://www.cdc.gov/nchhstp/newsroom/docs/Fact-Sheet-on-HIV-Estimates.pdf

  • Centers for Disease Control and Prevention (2011). High-impact HIV prevention: CDC’s approach to reducing HIV infections in the United States. Retrieved January 30, 2012, from http://www.cdc.gov/hiv/strategy/dhap/pdf/nhas_booklet.pdf

  • Des Jarlais, D. C., Braine, N., & Friedman, P. (2007). Unstable housing as a factor for increased injection risk behavior at US syringe exchange programs. AIDS Behavior, 11(Suppl. 6), 78–84.

    Article  PubMed  Google Scholar 

  • Des Jarlais, D. C., Kling, R., Hammett, T. M., Ngu, D., Liu, W., Chen, Y., et al. (2007). Reducing HIV infection among new injecting drug users in the China-Vietnam cross-border project. AIDS, 21(suppl. 8), S109–S114.

    Article  PubMed  Google Scholar 

  • Des Jarlais, D. C., Marmor, M., Paone, D., Titus, S., Perlis, T., Jose, B., et al. (1996). HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet, 348(9033), 987–991.

    Article  PubMed  CAS  Google Scholar 

  • Des Jarlais, D. C., & Semaan, S. (2008). HIV prevention for injecting drug users: The first 25 years and counting. Psychosomatic Medicine, 70, 606–611.

    Article  PubMed  Google Scholar 

  • Fiellin, D. A., Green, T. C., & Heimer, R. (2008). Combating the twin epidemics of HIV/AIDS and drug addiction: Opportunities for progress and gaps in scale, a report of the CSIS task force on HIV/AIDS. Retrieved February 1, 2012, from http://csis.org/files/media/csis/pubs/080129_fiellincombatinghiv.pdf

  • Fuller, C. M., Galea, S., Caceres, W., Blaney, S., Sisco, S., & Vlahov, D. (2007). Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. American Journal of Public Health, 97(1), 117–124.

    Article  PubMed  Google Scholar 

  • Gostin, L. O., Burris, S., Lazzarini, Z., & Maguire, K. (1998). Improving state law to prevent and treat infectious disease. Milbank Memorial Fund Report.

    Article  PubMed  Google Scholar 

  • Groseclose, S. L., Weinstein, B., Jones, T. S., Valleroy, L. A., Fehrs, L. J., & Kassler, W. J. (1995). Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers – Connecticut, 1992–1993. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10, 82–89.

    Article  PubMed  CAS  Google Scholar 

  • Hall, H. I., Ruiguang, S., Rhodes, P., Prejean, J., An, Q., Lee, L. M., et al. (2008). Estimation of HIV incidence in the United States. Journal of the American Medical Association, 300(5), 520–529.

    Article  PubMed  CAS  Google Scholar 

  • Harm Reduction Coalition (HRC, 2008). Syringe exchange research update, Harm Reduction Coalition, August 2008. Retrieved January 24, 2012, from http://www.harmreduction.org/downloads/Syringe%20Exchange%20Research%20Update%202008.doc

  • Holtgrave, D. R., Pinkerton, S. D., Jones, T. S., Lurie, P., & Vlahov, D. (1998). Cost and cost-effectiveness of increasing access to sterile syringes and needles as an HIV prevention intervention in the United States. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 18(Suppl.1), S133–S138.

    Article  PubMed  Google Scholar 

  • Jenkins, C., Rahman, H., Saidel, T., Jana, S., & Hussain, A. M. Z. (2001). Measuring the impact of needle exchange programs among injecting drug users through the national behavioural surveillance in Bangladesh. AIDS Education and Prevention, 13(5), 452–461.

    Article  PubMed  Google Scholar 

  • Jones, S. T., & Coffin, P. O. (2002). Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal. Journal of the American Pharmaceutical Association, 42(6)(Suppl. 2), S6–S9.

    Article  PubMed  Google Scholar 

  • Lane, S. D., Stryker, J., & Smith, M. (1992). Needle exchange: A brief history. A publication from the Kaiser Forums. Retrieved January 30, 2012, from http://hpcpsdi.rutgers.edu/facilitator/SAP/downloads/articles%20and%20data/History+of+Needle+Exchange.pdf

  • Latkin, C. A. (1998). Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users’ networks. Public Health Reports, 113(Suppl 1), 151–159.

    PubMed  CAS  Google Scholar 

  • Laufer, F. N. (2001). Cost-effectiveness of syringe exchange as an HIV prevention strategy. Journal of AIDS, 28(3), 273–278.

    PubMed  CAS  Google Scholar 

  • Martinez, J. B. (2007). Narrative, science-based literature on syringe exchange programs (SEPs), 1996–2007. Retrieved January 30, 2012, from: http://harmwp.live.radicaldesigns.org/wp-content/uploads/2012/01/SEPLitReview2007.pdf

  • Needle, R. H., & Zhao, L. (2010). HIV Prevention among injection drug users: Strengthening U.S. support for core interventions: A report of the CSIS Global Health Policy Center. Retrieved January 31, 2012, from http://csis.org/files/publication/100408_Needle_HIVPrevention_web.pdf

  • Palmateer, N., Kimber, J., Hickman, M., Hutchinson, S., Rhodes, T., & Goldberg, D. (2010) Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: A review of reviews. Addiction. Retrieved January 28, 2012, from http://www.ncbi.nlm.nih.gov/pubmed/20219055

  • Taussig, J. A., Weinstein, B., Burris, S., & Jones, T. S. (2000). Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. AIDS, 14(suppl 1), S47–S51.

    Article  PubMed  Google Scholar 

  • UNAIDS (2010). 2010 global report. Retrieved January 27, 2012, from www.unaids.org/globalreport/global_report.htm

  • Urban Coalition for HIV/AIDS Prevention Services (2010). Syringe Access. UCHAPS Best Practices, October 1, 2010.

    Google Scholar 

  • Wodak, A., & Cooney, A. (2006). Do needle syringe programs reduce HIV infection among injecting drug users: A comprehensive review of the international evidence. Substance Use Misuse, 41(6–7), 777–813.

    Article  PubMed  Google Scholar 

  • Wu, Z., Luo, W., Sullivan, S. G., Rou, K., Lin, P., Liu, W., et al. (2007). Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China. AIDS, 21(suppl. 8), S115–S122.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Rachel E. Golden or Rachel E. Golden .

Appendices

Case Study 1: Legalization of Needle and Syringe Sale and Possession: Effect on Connecticut Injection Drug Users’ Injection Practices

Original Program Developers and Evaluators

Samuel Groseclose

Linda A. Valleroy

Beth Weinstein

Laura J Fehrs

T.Stephen Jones

William J. Kassler

Chapter Contents

  • Abstract

  • Program at a Glance

  • Program Information and Implementation

  • Original Program Evaluation

  • Implications and Lessons Learned

  • Supplementary Materials Available

Bibliography

Groseclose, S. L., Weinstein, B., Jones, T. S., Valleroy, L. A., Fehrs, L. J., & Kassler, W. J. (1995). Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers—Connecticut, 1992–1993. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 10(1), 82–89.

Abstract

Syringe and needle sharing among injection drug users (IDUs) has the potential to spread HIV in addition to other blood-borne pathogens. IDUs can prevent new HIV infections with the consistent use of sterile drug-injecting equipment or the cessation of injection drug use altogether. While many IDUs know how to avoid HIV infection through safer injection practices, the restricted availability of syringes contributes to the continued use of contaminated syringes and needles. For IDUs unwilling or unable to enter drug treatment, increased sterile syringe and needle availability decreases the likelihood of needle and syringe sharing.

In May 1992, the state of Connecticut passed two new laws permitting (1) pharmacists to sell up to 10 syringes to individuals without a prescription and (2) individuals without medical prescriptions to possess up to 10 syringes without drug residue. Both laws took effect on July 1, 1992.

Researchers conducted two surveys about behaviors before and after the new legislation among IDUs in four Connecticut towns. They conducted a baseline survey 1–4 months after the new laws were enacted (from August through November 1992) and asked 124 IDUs to describe their practices and behaviors during June 1992 (the 30-day period just before the laws were implemented and 2–4 months before the interview). Eight to 11 months after the new law went into effect, the researchers conducted a second survey with 134 IDUs to determine subsequent practices. In addition to demographic data, they collected information about needle and syringe sharing, ownership, and origination source.

At baseline, 52 % of IDUs who reported ever sharing a syringe had done so in the past 30 days compared to 31 % at the time of follow-up, reflecting a significant change. At baseline, more IDUs reported that they obtained syringes on the street, in a “shooting gallery,” and from other sources rather than from pharmacies and needle exchanges. Significantly more IDUs reported obtaining syringes from pharmacies and needle exchanges in the follow-up survey. In addition, Hartford, Connecticut, police officers reported having fewer needlestick injuries in the 6 months after the laws changed compared to the 6 months before. It took time for the IDU community to become aware of the Connecticut laws, with significantly more IDUs knowledgeable during the follow-up survey compared to the baseline survey.

The evaluation of injection practices among IDUs before and after the change in Connecticut laws revealed a significant improvement in both syringe practices and knowledge of the laws. Although the incidence of HIV infection was not measured directly during this study, the increased use of sterile needles and syringes may have translated into HIV transmission prevention.

Program at a Glance

Goal: To promote the use of sterile syringes among injection drug users (IDUs) in Connecticut, by making it legal for pharmacists to sell up to 10 syringes without a prescription and by allowing individuals without prescriptions to legally possess up to 10 syringes without drug residue

Target Populations: Injection drug users

Geographic Location and Region: Connecticut, USA

Establishment and Duration: The legislation change occurred in May 1992 and went into effect in July 1992.

Resources Required and Goods and Services Provided: Not applicable

Strategies and Components: Change in state legislation

Key Partners: Connecticut State Legislature

Key Evaluation Findings

Statistically Significant

  • Decreased needle sharing

  • Location change where IDUs obtained syringes

    • Increased obtaining from pharmacists and needles exchanges

    • Decreased obtaining from street sources and “shooting galleries”

  • Increased awareness of new laws among IDUs over time

  • Decreased police officer reports of needle-stick injuries

No Effect

  • No change in pharmacy prices of syringes

  • No change in percent of IDUs reporting that they always carry a syringe with them

Program Information and Implementation

Background, History, and Public Health Relevance

Drug paraphernalia and syringe prescription laws create a serious impediment to the accessibility of sterile drug injection equipment for IDUs in the United States. In some states, it is illegal both to sell and possess needles and syringes without a medical prescription. Without easy access to sterile syringes and needles, IDUs resort to needle sharing with other IDUs, which increases the risk of HIV transmission.

Until 1992, the State of Connecticut had prohibitive syringe prescription and drug paraphernalia laws, and in the 1990s, the state was experiencing widespread HIV transmissions associated with injection drug use. In 1992, one out of every 10,000 Connecticut residents was an HIV/AIDS positive injection drug user. Forty percent of all HIV/AIDS cases reported that year were among IDUs.

Theoretical Basis

The law changes were grounded in the principles of harm reduction, which focuses on reducing the negative effects from unsafe behaviors rather than the occurrence of unsafe behaviors.

Objectives

The law changes aimed to increase the use of new, sterile injection drug-use equipment by increasing the accessibility and availability of new needles and syringes to injection drug users.

Class and Type of Outcome or Behavior Change Targeted

  • ☑ Decrease IDU risk

  • ☐ Decrease noncommercial sex risk

  • ☐ Decrease commercial sex risk

  • ☐ Increase health services utilization (exams, testing, and treatment)

Target Population and Venue for HIV Prevention

The laws apply to injection drug users residing in the State of Connecticut.

Pathways for Structural Change

  • ☐ Changes in programs

  • ☐ Changes in practices

  • ☑ Changes in policies and laws

The intervention operated through a change in laws regarding the availability and accessibility of sterile needles and syringes for injection drug users.

Strategies and Tactics for Structural Change

The intervention focused on the legal environment of the target population through changes in Connecticut state legislation. Local political organizing and coalition building were key strategies employed to bring about the law changes. To legalize needle-exchange program activities, beginning in 1987, the New Haven AIDS activity community lobbied the state legislature to repeal the state law banning the purchase or possession of syringes without a prescription. In 1990, the community was able to negotiate an exception to syringe prohibition legislation, allowing state financial support for a demonstration needle-exchange program and evaluation. A needle-exchange program in New Haven was operated for a year, trading up to five needles and syringes per IDU at a time, with accurate records kept of all exchanges. The program was successful, with more than 200 different customers visiting the exchange site in the first 30 days.

A team of researchers at Yale University evaluated the demonstration program and released a report in July 1991 detailing the success of the program. The needle-exchange program may have reduced HIV transmission by a third, based on the drug use and HIV risk behaviors reported from 720 IDUs and 1370 syringe tests. The success of the demonstration program influenced the political agenda of the Connecticut state legislature in 1992. In addition to repealing laws prohibiting syringe possession without a prescription, Connecticut increased the number of sanctioned and funded needle-exchange programs and raised the number of syringes that could be exchanged at a time to ten.

Core Components

  • Political organizing and coalition building

  • AIDS activists lobbying state legislature

  • Demonstrated public health benefit of needle exchange

  • Prohibitive needle purchase and possession legislature repealed

Resources Required

Not applicable

Management Structure

Not applicable

Implementation Themes

Legalizing the sale of and possession of sterile needles and syringes helped to promote the use of new injection drug equipment by injection drug users.

Main Challenges Faced

The unwillingness of some pharmacists to sell syringes to IDUs may have decreased the efficacy of this intervention.

Program Continuity and Present-Day Status

The law changes remain in effect in Connecticut at the time of this publication, most states in the USA have adopted similar legislation allowing injection drug users legal access to new needles and syringes.

Other Locations and Regions that Have Implemented Similar Programs

All of the states in the USA except Delaware and New Jersey have passed similar legislation. Similar needle and syringe allowances are found in Western Europe, much of Central and Eastern Europe, Australia, New Zealand, and Oceana.

Original Program Evaluation

Study Design

Timeline and Duration

New laws regarding the sale and possession of sterile needles and syringes in Connecticut were passed in May 1992 and went into effect on July 1, 1992. A baseline survey was conducted from August through November 1992, with the researchers asking injection drug users about their behaviors in June 1992 (the 30-day period before the new laws were enacted). A follow-up survey was conducted in March through June 1993 and asked participants about their behaviors during the previous 30 days.

Cohorts
  • ☑ Cross-sectional (snap shots in time)

  • ☐ Longitudinal (same people followed over time)

Temporal Direction of Data Collection Relative to Intervention
  • ☑ Prospective

  • ☐ Retrospective

Researchers collected data prospectively. The nature of the data was based on subject recall of behavior in the last month and may be considered retrospective in that regard.

Assessment Time Points (Temporal Comparison)
  • ☑ Before and after intervention (baseline and follow-up measures)

  • ☐ After only

  • ☐ Serial (more than two measures taken over time)

Implementation Level (Geographic Comparison)
  • ☐ Countries

  • ☑ Regions (state level)

  • ☐ Counties

  • ☐ Cities

  • ☐ Towns

  • ☐ Villages

  • ☐ Households

  • ☐ Couples, pairs, and dyads

  • ☐ Individuals

Sampling Unit
  • ☐ Countries

  • ☐ Regions

  • ☐ Counties

  • ☐ Cities

  • ☐ Towns

  • ☐ Villages

  • ☐ Households

  • ☐ Couples, pairs, and dyads

  • ☑ Individuals

Recruitment Techniques

Researchers recruited IDUs from three health department-based HIV counseling and testing programs, three correctional facilities, and two drug treatment centers in four Connecticut towns—Bridgeport, Hartford, Montville, and Waterbury.

Randomization
  • ☑ No

  • ☐ Yes

    • ☐ Random assignment

    • ☐ Random sampling

Randomization was not possible since the enacted laws applied statewide. Sampling was not random but was opportunistic in nature.

Study Type

Quasi-experimental

Methods

Data Collection
Data Sources
  • ☑ Questionnaire or survey

  • ☐ Chart information or surveillance

  • ☐ Record of biological specimen (e.g., urine sample)

Interview
  • ☑ Interviewer administered

  • ☐ Self-administered

Instruments
  • ☑ Paper and pencil (data entry after fieldwork)

  • ☐ Computer (ACASI or direct data entry in the field)

Modality
  • ☑ In-person

  • ☐ Mail

  • ☐ Phone

  • ☐ Internet

Staff members enrolled participants consecutively and interviewed IDUs at three health department-based HIV counseling and testing programs, three correctional facilities, and two drug treatment centers in four Connecticut towns. Only male IDUs were interviewed in correctional facilities and were interviewed within 7 days of being admitted or incarcerated.

Data Analysis

Outcome Variables Measured
  • ☑ Knowledge, attitudes, and beliefs

  • ☑ Behaviors and practices

  • ☐ Biomarker and clinical data

Variables Included
  1. 1.

    Knowledge of new laws—percent aware of partially repealed needle prescription and drug paraphernalia possession laws at the time of the initial survey and then after the new Connecticut laws at follow-up survey

  2. 2.

    Needle and syringe sharing—percent who ever shared a needle and syringe and percent who owned their own needle and syringe

  3. 3.

    Source of needle and syringe—on the street, in a pharmacy, in a “shooting gallery,” or a needle exchange

  4. 4.

    Other drug injection practices—duration of injection drug use, number of injections in the past 30 days, number of syringes owned at one time, and number of times a syringe was reused

  5. 5.

    Needlestick injury rates among Hartford police officers

Other Variables Measured
  • ☑ Demographics

  • ☐ Risk groups

  • ☐ Behaviors

Statistical Methods

The researchers compared sample means from the initial and follow-up surveys with independent two-sample t-tests. They used independent two-sample z-tests to compare rates and proportions between initial and follow-up surveys.

Strengths and Weaknesses of the Study Design and Methodology
  • ☐ Cross contamination between intervention and comparison groups

  • ☐ Concurrent interventions occurring in experimental or comparison areas

  • ☑ Historical bias or trend due to historical factors

Due to the large-scale implementation of the law changes, it was not possible for the researchers to randomly assign one region to the law changes and another as a control. Any differences between the two time points may have been caused by some other factor than the law changes. The IDU samples were not randomly selected, and the researchers acknowledge that their representativeness of the population was uncertain. The samples may have overrepresented ethnic and racial minorities. The study also relied on self-report data from IDUs who were asked to recall information about the recent past, which may be affected by intentional or unintentional bias.

Results

Sample Size

Baseline

Follow-up

Total

124

134

258

During the initial survey, the researchers asked 187 people to participate; 124 (66 %) IDUs were qualified and accepted, 9 (5 %) refused to participate, and 54 (29 %) had never injected drugs or were no longer actively injecting drugs and were ineligible. The researchers asked 210 people to participate in the follow-up survey: 134 (64 %) qualified, 8 (4 %) refused to participate, and 68 (32 %) were ineligible.

Retention and Loss to Follow-Up (Cohort Studies Only)

Not applicable to this study

Sample Demographics
Age

The median age of both samples was 35 years (range 17–56 years).

Race or Ethnicity
 

Baseline (%)

Follow-up (%)

Non-Hispanic White

43

47

Hispanic

40

34

African American

17

19

Gender
 

Baseline (%)

Follow-up (%)

Male

79

83

Female

21

17

Sexual Orientation

Not reported

Outcome and Other Measures

Measure

Finding

Knowledge of new laws

Knowledge of the new laws increased among IDUs over time: Significantly more IDUs were aware of the new laws 8–11 months after they were enacted as compared to 2–5 months after they were enacted (p = 0.04). During the follow-up survey, 7 % did not know about either new law as compared to 23 % during the initial survey (p = 0.001)

Needle and syringe sharing

After the new laws were enacted, needle sharing decreased: The percent of IDUs who reported ever sharing a needle and syringe decreased from 68 % to 52 % (p = 0.03). The percent of IDUs who reported ever owning their own needle and syringe increased from 92 % to 99 % (p = 0.004)

Sources of needles and syringes

IDUs reported obtaining needles and syringes from safer sources after the new laws were enacted: On the follow-up survey, fewer IDUs reported purchasing needles and syringes on the street (74 % vs. 28 %; p < 0.0001) or in shooting galleries (45 % vs. 16 %; p < 0.001). In addition, more IDUs reported purchasing needles and syringes from pharmacies (47 % vs. 90 %; p < 0.0001) and needle exchanges (6 % vs. 19 %; p = 0.01) on the follow-up survey

Other injection drug practices

The duration of drug use and frequency of injection for IDUs in the initial and follow-up samples were similar: IDUs reported using drugs for a median of 14 years in the initial sample and 13 years in the follow-up sample (p = 0.61). IDUs in the initial sample reported a mean number of 143 injections in the previous 30 days, while those in the follow-up sample reported 124 (p = 0.13). The number of reported syringes owned at one time increased slightly, from 9 to 11 (p = 0.63). The number of times a syringe was reused remained stable over time (8 vs. 7 times; p = 0.65)

Needlestick injury rates

Needlestick injury rates among Hartford police officers decreased after the new laws were in effect (6 injuries in 1,007 drug-related arrests for the 6-month period before vs. 2 in 1,032 arrests for the 6-month period after)

The changes in Connecticut laws correlated with decreases in self-reported syringe sharing and increases in purchasing sterile syringes from reliable sources, suggesting that the simultaneous repeal of both prescription and paraphernalia laws worked as an HIV prevention strategy. The 39 % decrease in syringe sharing reported by IDUs in the follow-up sample represents a significant reduction in risk that may have led directly to a decrease in the transmission of HIV and other blood-borne pathogens.

Conclusions

The study suggests that new legislation in Connecticut had a positive impact on syringe-purchasing and syringe-sharing practices among IDUs. After the new laws went into effect, IDUs were more likely to purchase syringes in a pharmacy than to obtain them on the street or share them with another IDU. Furthermore, safer injection practices correlated with increased access to sterile syringes and knowledge of the new laws.

Implications and Lessons Learned

After Connecticut’s legal syringe sale laws went into effect and were proven successful, other states changed their legislation in an attempt to decrease needle sharing by legalizing needle and syringe sales in pharmacies. As of May 2011, the State of Delaware remains as the single US state not to have adopted similar syringe sale provisions for IV drug users.

In January 2011, a Senate committee of the State of New Jersey approved legislation that would allow pharmacies to sell up to 10 syringes to users without a prescription. While the bill, S-958, must still be approved by the Assembly and the governor, proponents are hopeful that the new laws will help slow the spread of HIV, since at least 40 % of the state’s HIV cases are linked to injection drug use.

Legalizing the nonprescription sale of needles and syringes is a cost-effective way for states to increase the availability of clean needles and syringes to IDUs. Although needle-exchange programs also increase the availability of new needles and syringes to this population, they are limited by funds and intolerant communities. Legalizing syringe sales in pharmacies is beneficial for IDUs in cities with limited or no needle exchanges or for IDUs who prefer to obtain syringes at pharmacies due to confidentiality issues.

Supplementary Materials Available

Connecticut General Statutes 21a-65(b)—Sale of hypodermic needles and syringes restricted

A Comprehensive Approach: Preventing Blood-Borne Infections Among Injection Drug Users

State and Local Policies Regarding IDUs’ Access to Sterile Syringes

Additional References

Bray, S., Lawson, J., & Heier, R. (2001). Doffing the cap: increasing syringe availability by law but not in practice, Connecticut, 1999. International Journal of Drug Policy, 12, 221–235.

Livio, S. K. (2011a). N.J. Senate committee OKs bill allowing people to buy syringes without a prescription. State House Bureau. Retrieved from http://www.northjersey.com/news/012011_NJ_Senate_committee_OKs_bill_allowing_people_to_buy_syringes_without_a_prescription.html

Livio, S. K. (2011b). New Jersey: Senate OKs bill to let pharmacies sell syringes. The Body: The Complete HIV/AIDS Resource. Retrieved from http://www.thebody.com/content/art60592.html

Case Study 2: The SHAKTI Intervention in Bangladesh: (Stopping HIV/AIDS through Knowledge and Training Initiatives) A Needle Exchange Program’s Effect on Injection Drug Users’ Injection

Original Program Developers and Evaluators

Carol Jenkins

Smarajit Jana

Habibur Rahman

A.M.Zakir Hussain

Tobi Saidel

Case Study Contents

  • Abstract

  • Program at a Glance

  • Program Information and Implementation

  • Original Program Evaluation

  • Implications and Lessons Learned

  • Supplementary Materials Available

Bibliography

Jenkins, C., Rahman, H., Saidel, T., Jana, S., & Hussain, A. M. Z. (2001). Measuring the impact of needle exchange programs among injecting drug users through the national behavioral surveillance in Bangladesh. AIDS Education and Prevention, 13(5), 452–461.

Abstract

Unsafe injection practices among injection drug users (IDUs) contribute significantly to the spread of HIV in Dhaka, Bangladesh. In August 1998, the National HIV Surveillance found that among a sample of 400 IDUs, 2.5 % were infected with HIV. IDUs in the Dhaka area averaged 20 injections per week, most of which were with shared needles and syringes. In order to curb the spread of HIV from IDUs to other high-risk groups (such as commercial sex workers [CSWs]) and to lower-risk groups (such as the partners of those who visit CSWs), CARE Bangladesh began to promote the use of safer injection practices among IDUs who were unable or unwilling to stop using injection drugs.

CARE Bangladesh established the SHAKTI (Stopping HIV/AIDS through Knowledge and Training Initiatives) project in 1995 with funding from the UK Department for International Development. The SHAKTI project’s goals were to reduce the transmission of HIV/AIDS in Bangladesh by helping high-risk populations adopt safer behaviors. The SHAKTI project included interventions in the cities of Tangail and Dhaka for street and brothel CSWs and interventions targeting IDUs in the cities of Dhaka and Rajshahi.

In Rajshahi, the SHAKTI project established needle-exchange programs (NEPs) in private residences frequented by IDUs (addas). The addas received daily deliveries of needles and syringes, and educators and supervisors were present at the addas to provide information about HIV risk and prevention tactics. By late 1999, the adda-based NEP was reaching an estimated 10–20 % of local IDUs.

In Dhaka, the SHAKTI project established drop-in centers to provide IDUs with general medical information, treatment for abscesses and STIs, a safe place to rest or socialize, and condoms. The condom distribution aspect of the drop-in centers was successful, and in mid-July 1999, approximately 16,000 condoms were being distributed every month across the wards of Dhaka. The SHAKTI project also established a NEP with peer outreach workers in Dhaka that in late 1999 was reaching approximately 3,500 IDUs with an average needle-exchange rate of 73 %.

The National HIV Surveillance has been monitoring the results of the SHAKTI program on HIV transmission and IDU behavior since the implementation of SHAKTI programs in Dhaka and Rajshahi. The first round of HIV surveillance, conducted in mid-1998, measured HIV and syphilis infection prevalence in Dhaka only and behavioral risk factors of injection drug use in both Dhaka and Rajshahi. The National HIV Surveillance also conducted a follow-up survey of behavioral risk factors in mid-1999, in Dhaka only.

A more recent study evaluated the results of the second round of surveys completed by the National HIV Surveillance between January 3 and March 25, 2000. Researchers conducted a full-scale mapping of both Dhaka and Rajshahi and identified sites where drugs were obtained or injected. In Dhaka, researchers interviewed 682 IDUs, and in Rajshahi, researchers interviewed 512 IDUs for the study. A private interview lasting approximately 25 min asked participants about injection behaviors and exposure to SHAKTI program interventions. After the interview, participants received a short educational briefing on HIV and STIs, a condom demonstration, and five condoms.

While the researchers were unable to compare statistically the first and second round of surveillance data because of sampling differences, it appeared that injection sharing decreased over time in both Dhaka and Rajshahi. In Rajshahi especially, participation in HIV intervention programs such as NEPs had a significant effect on needle sharing. IDUs were much less likely to have shared and more likely to have used new equipment if they were intervention participants. In Dhaka, intervention nonparticipants were more likely to have shared equipment than intervention participants. Unlike Rajshahi, in Dhaka, intervention participation was not a reliable predictor of needle non-sharing. The intervention in Rajshahi had a greater impact on the smaller, less mobile group of IDUs who consistently used injection drugs in the addas than it did on IDUs in Dhaka.

Program at a Glance

Goal: To reduce the spread of HIV in Bangladesh by promoting safer drug injection practices and safer sex among injection drug users (IDUs)

Target Populations: Male Bangladeshi injection drug users

Geographic Location and Region: The cities of Dhaka and Rajshahi in North Bengal, Bangladesh

Establishment and Duration: CARE Bangladesh established the SHAKTI project in 1995. In 1998, intervention activities began, and the first round of HIV surveillance was conducted in mid-1998. The second round of surveys was completed between January 3 and March 25, 2000.

Resources Required and Goods and Services Provided: Condoms and sterile syringes and needles to distribute free of charge, funding to establish drop-in centers and to staff the centers

Strategies and Components

  • Increased availability and accessibility of sterile needles and syringes and condoms

  • Targeted IDUs by providing drop-in centers offering health information and resources

Key Partners: An evaluation study used data gathered by the CARE Bangladesh SHAKTI project and the Bangladesh National HIV Behavioral Surveillance, 1998–2000. The UK Department for International Development (DFID) and Family Health International/IMPACT (USAID) provided funding for the SHAKTI project.

Key Evaluation Findings

Statistically Significant

  • There were a greater number of married, educated, and less mobile IDUs in Rajshahi compared to Dhaka.

  • There was more “cocktailing” and IV injecting (rather than intramuscular injecting) in Rajshahi.

  • A higher percent of IDUs never shared equipment in Rajshahi compared to Dhaka.

  • A higher percent of injections where equipment was not passed on and where equipment was not shared in either direction existed among NEP participants (compared to nonparticipants) in Dhaka and Rajshahi.

  • NEP participants were more likely to use new equipment only, never to pass on used equipment, and never to share in either direction than nonparticipants in Rajshahi.

  • A higher percent of injections were with new equipment only among NEP participants in Rajshahi as compared to nonparticipants.

No Effect

  • In Dhaka, NEP participants were no more likely than nonparticipants to use new equipment only, never to pass on used equipment, and to share in either direction.

  • There were no significant differences between the mean percent of injections with new equipment only between non-NEP participants and NEP participants in Dhaka.

Program Information and Implementation

Background, History, and Public Health Relevance

In 1995, CARE Bangladesh began the SHAKTI (Stopping HIV/AIDS through Knowledge and Training Initiatives) Project in order to help prevent the spread of HIV/AIDS among injection drug users (IDUs) in Bangladesh. The HIV prevalence in Bangladesh was relatively low at the time when compared to India and other parts of Southeast Asia, even among such high-risk groups as IDUs and CSWs. The SHAKTI project targeted specific at-risk populations by providing them with information and resources on adopting HIV preventive behaviors. The SHAKTI program was composed of four separate interventions: a brothel CSW intervention in Tangail, a street CSW intervention in Dhaka, scaling up interventions among IDUs in Rajshahi and men who have sex with men (MSM) in Dhaka, and an IDU intervention in Dhaka.

In 1997, CARE Bangladesh administered an intervention baseline survey in Dhaka that estimated the size of the IDU population and the extent of HIV-1 infection. In 1998, CARE Bangladesh assessed another six cities in Bangladesh and determined that a large population of IDUs existed in Rajshahi. In order to monitor HIV transmission throughout Bangladesh and the effectiveness of intervention programs, the National HIV Surveillance began a first round of IDU surveys in Dhaka and Rajshahi in mid-1998. Since then, the National HIV Surveillance has measured IDU behavioral practices and IDU HIV rates on a consistent basis.

Previous evidence suggested that needle and syringe sharing were common practices among IDUs, and the SHAKTI intervention methods focused on accessible needle exchanges and teaching safer injection practices to IDUs.

Theoretical Basis

The program was grounded in the principles of harm reduction, which focus on reducing the negative effects from unsafe behaviors rather than the occurrence of unsafe behaviors themselves.

Objectives

The SHAKTI intervention aimed to decrease risky sexual and drug use risk-related behaviors in order to decrease HIV and STI transmission.

Class and Type of Outcome or Behavior Change Targeted

  • ☑ Decrease IDU risk

  • ☐ Decrease noncommercial sex risk

  • ☑ Decrease commercial sex risk

  • ☑ Increase health services utilization (exams, testing, and treatment)

Target Population and Venue for HIV Prevention

Injection drug users in Dhaka and Rajshahi cities are the focus of the evaluation

Pathways for Structural Change

  • ☑ Changes in programs

  • ☑ Changes in practices

  • ☐ Changes in policies and laws

The intervention operated through changes to programs to increase the availability and accessibility of resources such as health care, needles and syringes, and condoms to IDUs. The SHAKTI project also operated through changes to the practices of NEPs to increase the reach of services to IDUs.

Strategies and Tactics for Structural Change

The intervention targeted physical and social environments in the following ways:

Changes to the physical environment

Description

Drop-in centers

In Dhaka, seven drop-in centers provided IDUs a safe place to find information, socialize, seek medical treatment, and obtain condoms. A doctor saw drop-in center clients once a week to treat abscesses and STIs and to provide medical advice

Condom distribution

Condoms were distributed on a large scale as part of the intervention in Dhaka. In 1999, the SHAKTI project distributed approximately 16,000 condoms every month across the wards of the city

Needle exchange

In Dhaka, the SHAKTI project established a needle-exchange program so IDUs could exchange and obtain sterile needles and syringes on a daily basis. Peer outreach workers (current drug users who agreed not to carry or inject drugs while working) passed out new needles and offered health services in places where IDUs gathered. In Rajshahi, a needle-exchange program operated through residential addas (private residences that IDUs used as injection facilities) where new needles and syringes were delivered on a daily basis

Changes to the social environment

Description

Peer outreach

In Dhaka, peer outreach workers staffed drop-in centers daily and worked with IDUs in the community. In Rajshahi, educators were present at addas to supervise injection practices and provide information about safer injecting behaviors

Core Components

The SHAKTI intervention components worked together to bring about safer behaviors. Needle exchanges operated in the larger community through the work of peer educators or in addas where IDUs congregated. Condoms and needles and syringes were distributed and made widely available. Peer educators and peer outreach workers spread information about safer sex, safer injecting practices, and STI or abscess treatment.

Resources Required

The program required condoms and sterile syringes and needles to distribute free of charge and funding to establish drop-in centers and to staff the centers.

For the first 3 years, the cost of the intervention in Dhaka totaled $758,714 (US dollars). Forty-five percent of the costs went to local staff members, and 16 % went to international staff members. Thirteen percent of the total was allocated to needle and syringe costs. Approximately $110 (US dollars) were spent for every HIV infection averted among IDUs and their partners, and overall, the intervention cost $330 (US dollars) for every person reached.

Management Structure

Not reported

Implementation Themes

Employing the help of peer educators and peer outreach workers greatly expanded the reach of the SHAKTI program. In Dhaka, 26 peer outreach workers were trained on how to educate, offer health services, and distribute new needles to other IDUs. Peer outreach workers were current drug users who were asked not to carry or inject drugs during work hours or be involved in petty crime. They were provided with outreach ID cards to carry while at work. The SHAKTI program also trained 160 peer educators to distribute information to other IDUs. Those individuals were not on the SHAKTI project staff, but were encouraged to provide relevant information to peers when possible.

Main Challenges Faced

The researchers encountered difficulties in persuading IDUs to wait for and participate in interviews because of worry over potential police harassment. The researchers dealt with this by offering tea to potential interviewees, which helped to persuade them to wait for their interview. The strategy reduced the number of men who left the premises before they could be interviewed.

The adda-based NEP in Rajshahi had the unanticipated problem of attracting IDUs to the addas that participated in the program. The program operated in 10 addas, and IDUs who had not been using those particular addas before the SHAKTI program then began to come to them, causing some anger among adda owners.

Program Continuity and Present-Day Status

The SHAKTI project evolved to meet other HIV/AIDS-related needs in Bangladesh. It led to the RASTTA Bondor project, which aimed to reduce the spread of the HIV/AIDS virus among Bangladeshis with high-risk behaviors: truckers, sailors, and CSWs based in border and port areas. The RASTTA Bondor project lasted from 2000 to 2005 and promoted safer sexual practices, provided awareness training and messages, improved access to effective treatment for sexually transmitted diseases, and ensured easy access to condoms. The RASTTA Bondor project fell short of reaching its long-term sustainability goals, however, because of various technical problems and organizational capacity deficits.

Other Locations and Regions that Have Implemented Similar Programs

  • The five cities project in India, launched by SHARAN in 1999, addressed the spread of HIV and hepatitis B and C among IDUs in five major cities in India: Delhi, Mumbai, Kolkata, Chennai, and Imphal. The project created needle and syringe-exchange programs in as many as nine locations in each city. It also provided resources such as drop-in centers to reduce criminal activities associated with injection drug use and improve treatment and care services for IDU physical and mental health.

  • The drug-user advocacy group Junkie Union of Rotterdam in the Netherlands established an outreach and NEP in the early 1980s to help prevent the spread of HIV and hepatitis. Peer outreach workers brought injection equipment to IDUs to reduce the risks associated with shared equipment.

  • The Porto Alegre Harm Reduction Program in Brazil was established in 1996 to provide resources to IDUs. IDUs were reached through fixed and mobile teams that distributed new needles and syringes, counseling, and basic health care. IDUs were also given prevention kits containing syringes, needles, swabs, condoms, distilled water, a pot for dilution, an information leaflet, and a card with NEP addresses and phone numbers.

Original Program Evaluation

Study Design

Timeline and Duration

CARE Bangladesh established the SHAKTI project in 1995 with funding from the UK Department for International Development. Intervention activities began in Dhaka and Rajshahi in 1998. The first round of HIV surveillance was conducted in mid-1998. Behavioral risk factors were measured in a follow-up survey in mid-1999 in Dhaka. A second round of surveys was completed between January 3 and March 25, 2000.

Cohorts
  • ☑ Cross-sectional (snap shots in time)

  • ☐ Longitudinal (same people followed over time)

Temporal Direction of Data Collection Relative to Intervention
  • ☐ Prospective

  • ☑ Retrospective

Researchers collected data about drug-use behaviors in the previous week. In addition, data were collected after the intervention activities had been running in the intervention cities for about 2 years.

Assessment Time Points (Temporal Comparison)
  • ☐ Before and after intervention (baseline and follow-up measures)

  • ☑ After only

  • ☐ Serial (more than two measures taken over time)

Implementation Level (Geographic Comparison)
  • ☐ Countries

  • ☐ Regions

  • ☐ Counties

  • ☑ Cities

  • ☐ Towns

  • ☐ Villages

  • ☐ Households

  • ☐ Couples, pairs, and dyads

  • ☐ Individuals

Sampling Unit
  • ☐ Countries

  • ☐ Regions

  • ☐ Counties

  • ☐ Cities

  • ☐ Towns

  • ☐ Villages

  • ☐ Households

  • ☐ Couples, pairs, and dyads

  • ☑ Individuals

  • ☑ Other (primary sampling units)

To develop an accurate sampling frame, all wards of Dhaka and Rajshahi were mapped to determine the locations where no less than five IDUs were present between 8 and 12 am or 2 and 6 pm. These locations and their associated 4-h times were assigned a number as a primary sampling unit (PSU), forming the basis for randomization. PSUs were randomly selected for sampling, and every IDU seen during the 4-h time was interviewed.

Recruitment Techniques

Researchers approached every IDU seen at each selected PSU for an interview. In Dhaka, a total of 53 PSUs were randomly selected, and in Rajshahi, a total of 25 PSUs were randomly selected. Fewer PSUs were selected in Rajshahi because duplication was highly likely, so the sample strategy was adjusted.

Randomization
  • ☐ No

  • ☑ Yes

    • ☐ Random assignment

    • ☑ Random sampling

Recruitment into the study was random since researchers randomly selected PSUs to sample.

Study Type

Quasi-experimental

Methods

Data Collection
Data Sources
  • ☑ Questionnaire or survey

  • ☐ Chart information or surveillance

  • ☐ Record of biological specimen (e.g., urine sample)

Interview
  • ☑ Interviewer administered

  • ☐ Self-administered

Instruments
  • ☐ Paper and pencil (data entry after fieldwork)

  • ☐ Computer (ACASI or direct data entry in the field)

  • ☑ Not reported

Modality
  • ☑ In-person

  • ☐ Mail

  • ☐ Phone

  • ☐ Internet

Staff member interviewers were trained to find private, out-of-the-way places to conduct the interviews.

Data Analysis

Exposure Variables Measured

Self-reported participation in an HIV prevention program

Predictor Variables Measured

Survey respondents self-reported their past exposure to and participation in HIV prevention programs. Of those who reported exposure and participation, most (100 % in Dhaka and 95 % in Rajshahi) reported their exposure and participation to be in NEPs.

Researchers also used city (Dhaka and Rajshahi) as predictor variables.

Outcome Variables Measured
  • ☐ Knowledge, attitudes, and beliefs

  • ☑ Behaviors and practices

  • ☐ Biomarker and clinical data

Sharing behaviors of injection drug use, such as using only new equipment or not passing on equipment, were measured.

Other Variables Measured
  • ☑ Demographics

  • ☐ Risk groups

  • ☐ Behaviors

Statistical Methods

Data were cleaned and analyzed with the software program Stata 6. Comparisons between groups were made with Pearson’s chi-square tests for proportions and t-tests for means. Significant variables were entered into a multiple logistic regression to test their importance in explaining variation in the injection safety variable. All tests used Stata’s cluster adjustments to account for design effects.

Strengths and Weaknesses of the Study Design and Methodology
  • ☐ Cross contamination between intervention and comparison groups

  • ☐ Concurrent interventions occurring in experimental and comparison areas

  • ☐ Historical bias or trend due to historical factors

To evaluate the effects of the program components, the researchers relied on self-report from IDUs to indicate if they had been exposed to elements of the intervention. Because random assignment to intervention exposure was not possible with this program, the possibility exists that self-selection bias applies.

Results

Sample Size

Dhaka

Rajshahi

Total

679

508

1,187

Retention and Loss to Follow-Up (Cohort Studies Only)

Not applicable to this study

Sample Demographics
Age
 

Dhaka

Rajshahi

Mean age

35

35

Race or Ethnicity

Not reported

Gender
 

Dhaka (%)

Rajshahi (%)

Male

100

100

Sexual Orientation

Not reported

Outcome and Other Measures

Measure

Finding

Demographic characteristics

Significantly more IDUs in Rajshahi were married and educated than in Dhaka. Dhaka had twice the proportion of homelessness and more rickshaw pullers than Rajshahi indicating that the IDU population in Dhaka was more mobile than the IDU population in Rajshahi

Drug-use factors

The duration of drug use as well as the duration of injecting were greater in Dhaka than in Rajshahi. “Cocktailing” (mixing less-expensive drugs such as diazepam and chlorpheniramine in order to reduce monetary costs and effects of withdrawal) more frequently occurred in Rajshahi. There was a higher proportion of intravenous injecting (rather than intramuscular injecting) in Rajshahi, since professionals were available in the addas to administer injections to IDUs

Equipment sharing

A significantly higher percentage of men in Rajshahi had never shared injection equipment (44.7 %) than in Dhaka (25.2 %; p < 0.05) in the last week. In Dhaka, the percent of injections after which equipment was not passed on to another IDU and where equipment was not shared in either direction was significantly higher for NEP participants than non-NEP participants. This was also true in Rajshahi, in addition to four additional measures of safer injecting practices. NEP participants were more likely to use only new equipment, never pass on used equipment, never share in either direction, and have a higher percent of injections with only new equipment

Equipment sharing over time

It was not possible for researchers to statistically compare data from the first and second rounds of HIV surveillance due to different sampling strategies. They concluded that the differences suggested a positive change, however. Sharing behaviors were reduced in both Dhaka and Rajshahi in 2000 as compared to 1998

Conclusions

The implementation of the NEP and HIV intervention programs of the SHAKTI project reduced the sharing behaviors of IDUs likely to transmit HIV. The researchers noted that consistent results from several surveys at different times suggested that the proportion of men who never share injection equipment had increased, although this observation was difficult to support with the cross-sectional comparison the researchers employed. The intervention seemed to have been most effective in Rajshahi, and the researchers offered a compelling explanation for the finding. The nature of the NEP in Rajshahi, with needles and syringes delivered daily to cooperative adda owners at private residences serving a specific group of men under the supervision of an educator, encouraged greater consistency of safe injecting. The researchers found significant differences in sharing practices among men who reported participating in addas and those who did not, which suggested that intervention tactics were successfully changing injection practices. The difference between Dhaka and Rajshahi suggested that providing a stable, safe environment to IDUs reduces the harm associated with injecting where there are high levels of homelessness and mobility.

Implications and Lessons Learned

The early needle-exchange intervention efforts in Bangladesh helped to delay an HIV epidemic that had been predicted for the country. Since adjacent countries (Myanmar and India) had a high HIV prevalence, the fact that Bangladesh has remained a low-prevalence nation points to the success of the early implementation of the NEPs in the 1990s.

The intervention may have delayed an HIV epidemic because of the high number of needles and syringes that were distributed per IDU over time. It was estimated that IDUs received 24–29 needles and syringes per month, many more than typically received by IDUs during needle-exchange programs. The exchange rate was also very high (72–83 %), indicating that needles and syringes were taken out of circulation, reducing the possibility that they would be used repeatedly.

While the overall HIV prevalence has remained low for the country (<1 % in 1995), the high concentration of IDUs in the capital city of Dhaka has contributed to a recent rise in new HIV infections. From a serological surveillance conducted in 2006, the HIV prevalence in Dhaka was 7 %, a significant increase from surveillance rounds conducted in previous years. The rise in HIV prevalence signifies the conversion of Bangladesh from a low-prevalence country to one with a concentrated epidemic. Although the epidemic appears to be localized to one specific neighborhood in Dhaka, the continued needle sharing practices of IDUs will likely contribute to an expanding epidemic across the nation.

Supplementary Materials Available

Bangladesh Country Advocacy Brief: Injecting Drug Use and HIV

Additional References

Azim., T., Rahman, M., Alam, M. S., Chowdhury, I. A., Khan, R., Reza, M., et al. (2008). Bangladesh moves from being a low-prevalence nation for HIV to one with a concentrated epidemic in injecting drug users. International Journal of STD & AIDS, 19, 327–331.

Beg, M. (1999). SHAKTI: Working with injecting drug users in Bangladesh. AHRN Newsletter 16, July–August 1999.

Foss, A. M., Watts, C. H., Vickerman, P., Azim, T., Guinness, L., Ahmed, M., et al. (2006). Could the CARE-SHAKTI intervention for injecting drug users be maintaining the low HIV prevalence in Dhaka, Bangladesh? Addiction, 102, 114–125.

Guinness, L., Vickerman, P., Quayyum, Z., Foss, A., Watts, C., Rodericks, A., et al. (2009). The cost-effectiveness of consistent and early intervention of harm reduction for injecting drug users in Bangladesh. Addiction, 105, 319–328.

Case Study 3: Providing a Safer Injection Facility to Injection Drug Users: InSite: A Safer Injection Facility in Vancouver, British Columbia

Original Program Developers and Evaluators

Evan Wood

David C.Marsh

Thomas Kerr

Julio SG Montaner

Elisa Lloyd-Smith

Mark Tyndall

Kathi Li

Will Small

Case Study Contents

  • Abstract

  • Program at a Glance

  • Program Information and Implementation

  • Original Program Evaluation

  • Implications and Lessons Learned

  • Supplementary Materials Available

Bibliography

Wood, E., Kerr, T., Lloyd-Smith, E., Buchner, C., Marsh, D. C., Montaner, J., et al. (2004). Methodology for evaluating InSite: Canada’s first medically supervised safer injection facility for injection drug users. Harm Reduction Journal, 1(9), 1–5.

Kerr, T., Tyndall, M., Li, K., Montaner, J., & Wood, E. (2005). Safer injection facility use and syringe sharing in injection drug users. Lancet, 366, 316–318.

Abstract

In September 2003, Vancouver, British Columbia, opened a safer injecting facility (SIF) in the Downtown Eastside neighborhood, in the heart of the city’s injection drug-user (IDU) population. The facility, InSite, was the first SIF to be opened in North America, and its opening was not without significant controversy. While other SIFs had been opened and were operating in European cities (e.g., in Germany, Switzerland, and Amsterdam), the effects of these facilities on IDUs and the surrounding communities had not been rigorously evaluated. InSite was granted legal immunity by the Canadian federal government for 3 years of operation on the condition that its effects be closely evaluated.

InSite has remained in operation up to the time of this publication. It offers IDUs a safe place to inject pre-obtained drugs: 12 injection stalls, nurses to treat overdoses and abscesses, and sterile drug-injecting equipment. In addition, IDUs are offered referrals to addiction treatments and detoxification centers.

Several research studies evaluated the effects of the SIF on IDU clients and the surrounding community. Researchers compared drug-use behavior of IDUs using the facility with IDUs not using the facility by using previously collected data (such as the Vancouver Injection Drug Users Study). They used a prospective cohort design with longitudinal measurements of risk behaviors and drug-use behaviors with a selected InSite population (the SEOSI—Scientific Evaluation of Supervised Injecting cohort). Participants were randomly selected into the sample, but participation in selected research activities was voluntary, and by September 1, 2004, more than 900 InSite users were enrolled into SEOSI.

One concern at the start of the project was that InSite would not attract its target population. It was immediately evident that this would not be a concern; during an evaluation from March 2004 to April 2005, 5,000 IDUs used the facility, and 45 % of a sample of community-recruited IDUs reported that they had used the facility before. Factors that were found to make individuals more likely to use the facility on a daily basis included daily heroin or cocaine injection, homelessness, and not receiving methadone treatment.

Concerns about the facility’s potential negative effects were also identified and studied. There was no evidence that crime or drug dealing increased in the neighborhood after InSite’s opening. The presence of discarded syringes, public injection drug use, and injection litter all decreased in a 10-block radius around InSite after its opening. There were also concerns that InSite would lead to an increase in injection drug use among IDUs in the area and more new recruits to injection drug use. Neither of these occurred; in fact, the facility increased the uptake of addiction treatment of IDUs interested in detoxification. Safer injecting practices were evident in the IDU population after the facility’s opening. There was less equipment sharing associated with InSite users compared to those IDUs who did not come to InSite. There were approximately 1.3 overdoses per 1,000 injections, and no overdose-related deaths occurred.

Program at a Glance

Goal: To establish a SIF in Vancouver, British Columbia, Canada, where IDUs could inject drugs in a medically supervised environment. Goals included reducing public drug use, reducing fatal and nonfatal overdoses, reducing the spread of infectious diseases, improving contact between IDUs and the health-care system, and improving IDUs’ ability to access addiction treatment.

Target Populations: IDUs of any age, gender, and race or ethnicity

Geographic Location and Region: Downtown Eastside neighborhood of Vancouver, British Columbia, Canada

Establishment and Duration: Established September 2003 and still operating (2012)

Resources Required and Goods and Services Provided: The operational budget was $2,946,610 for 2008–2009. Funding provided a comprehensive support network for IDUs, including a team of nurses, counselors, mental health workers, and peer support workers. It also supported injection supplies (such as syringes, cookers, filters, water, and tourniquets) and health-care supplies (for wound care and immunizations) in addition to funding needed for the facility in general.

Strategies and Components

  • Targeted IDUs in a central drug-using neighborhood

  • Provided a safe, clean injection facility for IDUs to use for injecting drugs

  • Provided sterile injection equipment, emergency overdose care, and other health services

  • Provided supervised injecting by medical staff and advice on safer injecting practices

  • Encouraged and provided resources for addiction recovery

Key Partners: Vancouver Coastal Health Authority, Portland Hotel Society, Health Canada, and the British Columbia Ministry of Health

Key Evaluation Findings

Statistically Significant

  • Decreased public disorder and public drug use

  • Decreased needle and syringe sharing and reuse

  • Increased sterile water use and injecting in a clean environment

  • Increased entry into detox programs, with weekly use and contact with an addiction counselor

No Effect

  • Did not change incidence of overdose

  • Did not increase the number of drug trafficking incidents, assaults, robberies, or vehicle break-ins and thefts in the neighborhood

Program Information and Implementation

Background, History, and Public Health Relevance

In September 2003, Vancouver, British Columbia, with the support of the Canadian federal government, opened the first SIF in North America. The facility, InSite, opened in the Downtown Eastside neighborhood of Vancouver, one of the poorest neighborhoods in Canada. The neighborhood was considered to be the center of an injection drug epidemic. With the amenities provided by InSite, the Vancouver Coastal Health Authority and the British Columbia Ministry of Health Services hoped to reduce the harm faced by IDUs from injection-related risks, such as the transmission of HIV and other infectious diseases.

Anecdotal evidence pointing to the benefits of such an SIF was provided by similar centers across Europe, including those in Germany, Switzerland, and Amsterdam. However, none of the European facilities had undergone rigorous evaluation. The opening of InSite raised controversy in the community, especially since North America has always penalized illicit drug use. InSite was opened with a special exemption from Section 56 of the Controlled Drugs and Substances Act via Health Canada. The legal exemption was granted for 3 years with the provision that an external 3-year scientific evaluation be conducted on the SIF’s effects.

Theoretical Basis

InSite operated on a harm-reduction model, aiming to decrease the adverse health, social, and economic consequences of drug use without requiring abstinence from drug use.

Objectives

The establishment of a SIF aimed to reduce drug use in public, reduce overdoses, reduce the risk of infectious disease, improve IDU population contact with the health-care system, and increase uptake of addiction treatment by IDUs.

Class and Type of Outcome or Behavior Change Targeted

  • ☑ Decrease IDU risk

  • ☐ Decrease noncommercial sex risk

  • ☐ Decrease commercial sex risk

  • ☑ Increase health services utilization (exams, testing, and treatment)

Target Population and Venue for HIV Prevention

InSite targeted injection drug users in the Downtown Eastside neighborhood of Vancouver.

Pathways for Structural Change

  • ☑ Changes in programs

  • ☑ Changes in practices

  • ☑ Changes in policies and laws

The establishment of InSite required a change in government policy and law through a special exemption from the Controlled Drugs and Substances Act. Program and practice changes concerning the operation of InSite involved increasing the availability, accessibility, and acceptability of resources such as sterile drug injection equipment; addiction, detoxification, and overdose treatment; and care for abscesses.

Strategies and Tactics for Structural Change

The InSite facility had 12 injection stalls, and IDUs were provided with sterile syringes, needles, bandages, and alcohol swabs. IDUs were not provided with drugs at the facility, and drugs could not be bought or sold on the premises. Nurses were available to treat overdoses and abscesses, but they were not allowed to help with injections. In addition, IDUs could get primary care services at InSite and could be referred to addiction treatment services when requested.

Core Components

The creation of the injection facility first required a legal exemption from current law in order for InSite to allow supervised drug injections. Once the exemption was granted, the facility provided key services and resources to IDUs, including clean and sterile injection stalls, new injection equipment, medical staff for the facility, an addiction counselor, and health services and referral information.

Resources Required

InSite’s operational budget was $2,969,440 for 2010–2011. Funding provided a comprehensive support network for IDUs, including a team of nurses, counselors, mental health workers, and peer support workers. The funding also supported injection supplies (such as syringes, cookers, filters, water, and tourniquets) and health-care supplies (for wound care and immunizations), in addition to the support needed for the facility in general.

Management Structure

InSite staff included an addiction counselor, five to six program workers who assisted and supervised IDUs in a waiting room, two staff nurses, two peers who oversaw a “chill-out room”, and one supervisor.

Implementation Themes

The British Columbia Ministry of Health Services had to overcome the concerns of the local community with respect to hosting a SIF.

Main Challenges Faced

InSite opened with a constitutional exception to the Controlled Drugs and Substances Act and operated for 3 years under this exception and then for a further 22 months when an extension was granted. The Health Minister refused to allow the site’s legal exemption to continue past July 2008, but the British Columbia Supreme Court struck down the provisions of the Controlled Drugs and Substances Act dealing with possession and trafficking, allowing InSite to continue operating. The Attorney General of Canada appealed this decision, but in January 2010 the British Columbia Court of Appeals dismissed the appeal, allowing InSite to continue operations. The Attorney General filed a further appeal with the Supreme Court of Canada, and the case was heard in May 2011. On September 30, 2011, the Supreme Court of Canada denied the appeal by the Attorney General of Canada, allowing InSite to continue operations yet again.

InSite faced an additional challenge resulting from its overwhelming popularity among the local IDU population, which placed a significant strain on InSite’s ability to serve all who needed or wanted to use its services (W. Small, personal communication, June 3, 2011).

Since InSite was supposed to be available to all IDUs interested in attending, it was not possible (nor ethically desirable) to attempt to randomize IDUs into groups allowed to receive services versus groups not allowed for the purposes of a randomized, controlled study.

Program Continuity and Present-Day Status

InSite operates legally at the time of this publication under a constitutional exception to the Controlled Drugs and Substances Act. Since the opening of the facility, Vancouver Coastal Health and the PHS Community Services Society have worked together to increase outreach services to IDUs by creating OnSite, a detoxification center and transitional housing unit in the same location as InSite. In September 2007, OnSite began serving clients traditionally overlooked by more expensive drug treatment programs. OnSite frequently serves homeless drug users suffering from mental health issues who have been referred from the InSite facility downstairs.

While in transitional housing or in the detoxification program, IDUs can participate in a variety of programs, including counseling, yoga, meditation, acupuncture, relapse prevention, and 12-step programs. OnSite staff strive to maintain personal relationships with clients and to create a comfortable, easy-to-access community to facilitate drug abuse recovery.

Other Locations and Regions that Have Implemented Similar Programs

  • In Switzerland, the first supervised injection center opened in 1986. Currently, SIFs operate in Basel, Bern, Olten, Schaffhausen, Wattil, Wil, Solothum, St. Gallen, Winterthur, Chur, and Zurich. The centers typically include a café, a counseling room, and a clinic for medical care. Sterile injection rooms provide resources such as needles and syringes, sterile water, paper towels, cotton pads, and bandages. Physicians are available during limited hours, and staff are trained on overdose recovery procedures.

  • In Germany, the first SIF opened in 1994, with facilities now operating in Hamburg, Frankfurt, Hanover, and Saarbrucken. These hygienic, accessible, and anonymous facilities accept IDUs with little registration or assessment procedures. Facility staff commonly refer clients to detoxification and other health services in addition to providing oversight of injection practices and care in the case of overdose.

Original Program Evaluation

Study Design

Timeline and Duration

In this section, details are presented for only one InSite study focused on risk factors associated with syringe sharing among IDUs. Researchers evaluated a sample of InSite users (from the SEOSI cohort—Scientific Evaluation of Supervised Injecting) who had been randomly selected according to enrolment dates and times. For the study, SEOSI participants seen between December 1, 2003, and June 1, 2004 were included in the sample.

Cohorts
  • ☑ Cross-sectional (snap shots in time)

  • ☑ Longitudinal (same people followed over time)

Although the SEOSI sample was followed longitudinally, the majority of the findings presented here come from a one-time cross-section of the longitudinal data, supplemented with information gathered in the baseline wave of SEOSI.

Temporal Direction of Data Collection Relative to Intervention
  • ☑ Prospective

  • ☑ Retrospective

Data were collected prospectively, although participants were asked to report retrospectively about syringe sharing during the past 6 months.

Assessment Time Points (Temporal Comparison)
  • ☑ Before and after intervention (baseline and follow-up measures)

  • ☐ After only

  • ☐ Serial (more than two measures taken over time)

Implementation Level (Geographic Comparison)
  • ☐ Countries

  • ☐ Regions

  • ☐ Counties

  • ☑ Cities

  • ☐ Towns

  • ☐ Villages

  • ☐ Households

  • ☐ Couples, pairs, and dyads

  • ☐ Individuals

Sampling Unit
  • ☐ Countries

  • ☐ Regions

  • ☐ Counties

  • ☐ Cities

  • ☐ Towns

  • ☐ Villages

  • ☐ Households

  • ☐ Couples, pairs, and dyads

  • ☑ Individuals

Recruitment Techniques

Researchers recruited the SEOSI cohort by attending the facility at randomly selected times during the day and inviting all users who visited the site during that time to participate in the study.

Randomization
  • ☐ No

  • ☑ Yes

    • ☐ Random assignment

    • ☑ Random sampling

Participants in the study were not randomly assigned to a particular condition because the InSite facility was open for any IDU to use. Researchers did randomly sample InSite clients for the evaluation.

Study Type

Quasi-experimental

Methods

Data Collection
Data Sources
  • ☑ Questionnaire or survey

  • ☐ Chart information or surveillance

  • ☑ Record of biological specimen (e.g., urine sample)

IDUs volunteered to provide a blood sample and answer an interviewer-administered questionnaire, which asked about risk behaviors, public drug use, satisfaction with InSite, and access to medical care and addiction treatment services. SEOSI participants provided informed consent, so that their administrative health records in the community and at InSite could be tracked.

Interview
  • ☑ Interviewer administered

  • ☐ Self-administered

Instruments
  • ☐ Paper and pencil (data entry after fieldwork)

  • ☐ Computer (ACASI or direct data entry in the field)

  • ☑ Not reported

Modality
  • ☑ In-person

  • ☐ Mail

  • ☐ Phone

  • ☐ Internet

Interviewers conducted in-person interviews at the facility.

Data Analysis

Exposure Variables Measured

Number of injections undertaken at the facility (none or few vs. some, most, or all)

Outcome Variables Measured
  • ☐ Knowledge, attitudes, and beliefs

  • ☑ Behaviors and practices

  • ☐ Biomarker and clinical data

The outcome variable was syringe sharing—borrowing or lending a used syringe in the past 6 months.

Other Variables Measured
  • ☑ Demographics

  • ☑ Risk groups

  • ☑ Behaviors

The researchers accounted for age, HIV serostatus, previous access to sterile syringes, need for help with injections, binge drug use, frequent cocaine injecting, frequent heroine injecting, and methadone maintenance treatment.

Statistical Methods

The researchers used univariate and multivariate statistics to determine factors associated with syringe sharing. The associations between predictor and outcome variables were assessed by univariate logistic regression. To adjust for potential confounding between the use of InSite and syringe sharing, variables significantly associated with syringe sharing were then considered in a fixed logistic regression model. The researchers conducted all statistical analyses using SAS software version 8.0.

Strengths and Weaknesses of the Study Design and Methodology
  • ☐ Cross contamination between intervention and comparison groups

  • ☐ Concurrent interventions occurring in experimental and comparison areas

  • ☑ Historical bias or trend due to historical factors

The intervention condition was not randomly assigned to participants, presenting the possibility of a confounding factor influencing the syringe-sharing differences between InSite users and nonusers. To test if InSite users were inherently at a lower risk of syringe sharing, the researchers calculated the rate of syringe sharing before the site opened for those who used the facility and those who did not use the facility. The rates of sharing were similar in those populations. This prospective data implied that differences in the rate of syringe sharing emerged after the facility opened.

Results

Sample Size

431 active IDUs

Retention and Loss to Follow-Up (Cohort Studies Only)

Not applicable to this study

Sample Demographics

Not reported

Outcome and Other Measures

Measure

Finding

Syringe sharing

Use of InSite was independently associated with reduced syringe sharing (p = 0.02). Needing injection help, binge drug use, and frequent heroin or cocaine use were all associated with syringe sharing (p = 0.01, p = 0.03, p = 0.07, p = 0.08, respectively)

Characteristics of InSite users (from other studies of InSite)

45 % of community-recruited IDUs had used InSite. Characteristics that predicted InSite use: younger age, public injection drug use, homelessness or unstable housing, daily heroin or cocaine injection, and recent nonfatal overdose. Requiring help with injections was negatively associated with daily use of the facility

Public order (from other studies of InSite)

After InSite’s opening, measures of public disorder including discarded syringes, public injection drug use, injection-related litter, and presence of suspected drug dealers declined in the surrounding neighborhood

Crime (from other studies of InSite)

Crime rates remained stable in the neighborhood after InSite opened. There were not any increases in police charges for drug dealing, assaults, robbery, or vehicle break-ins

Use of education services (from other studies of InSite)

30 % of a random sample of InSite users reported receiving safer injecting education from InSite nurses. IDUs who first received help with injections were less likely to need assistance because of education from InSite nurses

Safer injecting behaviors (from other studies of InSite)

Use of InSite was independently associated with safer injection practices, including decreased reuse of syringes, increased use of sterile water, and increased use of alcohol swabs on the injection site

Addiction treatment (from other studies of InSite)

As many as 320 referrals were made per quarter to community addiction treatment resources. Weekly use of InSite and contact with the facility’s addiction counselor were associated with a more rapid entry into a detoxification program

Overdoses (from other studies of InSite)

The rate of overdose was approximately 1.3 per 1000 injections. 60 % of overdoses were successfully managed by facility support and 40 % required an ambulance call

Conclusions

Providing an injection facility for IDUs in an area with a concentrated population of IDUs led to improved personal health and community benefits. Public drug injections decreased resulting in less-dangerous injection-related litter being left in public areas. There were benefits to the IDUs, such as abscess and overdose treatment, and adoption of safer injecting practices as a result of consistently visiting the facility.

Implications and Lessons Learned

The success of InSite’s operation indicates the utility of such an intervention in neighborhoods where injection drug use is common and raises the question of whether such a facility could be successful in other settings. In addition to improving the health of the local IDU population, SIFs appear to provide a number of community benefits, including addressing public order issues such as injection litter and public injection practices. There has not been any evidence of community or health-related harm caused by the operation of a drug injection facility.

Supplementary Materials Available

Safe Injection Facilities: A Proposal for a Vancouver Pilot Project

Additional References

Wood, E., Tyndall, M. W., Montaner, J., & Kerr, T. (2006). Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ, 175(11), 1399–1404.

http://supervisedinjection.vch.ca/.

Case Study 4: Needle Social Marketing Strategy in China: Effect on Chinese Injection Drug Users’ Injection Practices

Original Program Developers and Evaluators

Zunyou Wu

Wei Luo

Sheena G.Sullivan

Keming Rou

Peng Lin

Wei Liu

Zhongqiang Ming

Chapter Contents

  • Abstract

  • Program at a Glance

  • Program Information and Implementation

  • Original Program Evaluation

  • Implications and Lessons Learned

  • Supplementary Materials Available

Bibliography

Wu, Z., Luo, W., Sullivan, S. G., Rou, K., Lin, P., Liu, W., et al. (2007). Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China. AIDS, 21(8), S115–122.

Abstract

China was experiencing a severe injection drug-use problem in 2005, with 1.16 million individuals registered as injection drug users (IDUs). Needle sharing among IDUs was common, and unsafe injection practices were contributing to a generalized HIV epidemic occurring in regions of China where up to 25 % of IDUs were thought to be living with HIV. Although China’s official stance was that harm reduction strategies promote drug use and should be illegal, the Ministry of Health had begun promoting needle social marketing strategies in 1998, in lieu of IDU health education, to reduce the transmission of HIV among the IDU community.

In two provinces (Guangdong and Guangxi), needle social marketing activities used local resources such as pharmacies, hospitals, and clinics to reach IDUs. Health workers handed out educational pamphlets, displayed educational posters, and delivered lessons about drug abuse and HIV/AIDS in detoxification centers and other health centers. In the community, health workers conducted face-to-face health education sessions and needle exchanges in IDU homes and places where they gathered.

Researchers conducted an evaluation of the needle social marketing strategy that aimed to reduce needle sharing, hepatitis C virus (HCV), and HIV transmission among IDUs in Guangdong and Guangxi provinces. They used a two-armed, prospective, community-randomized prevention trial. In each province, researchers randomized one county to the intervention condition and another to the control condition. Cross-sectional surveys at baseline and follow-up compared changes in drug using behaviors as well as HIV and HCV infection rates in the intervention and control communities. Needle sharing behaviors were similar in the two groups at baseline (68.4 % vs. 67.8 %), but dropped significantly to 35.3 % in the intervention community, while remaining relatively stable in the control community (62.3 %, P < 0.001). In a subset cohort of new injectors, the incidence of HCV was significantly lower in the intervention than in the control condition in both provinces individually (P < 0.001, P = 0.014) and collectively (P < 0.001), but HIV incidence was significantly lower only in the intervention group in Guangdong (P = 0.011).

The study demonstrated that needle social marketing effectively reduced some risky injection and sexual practices (i.e., needle sharing, not using a condom). In addition, it was effective in reducing HIV and HCV infection rates among IDUs who began injecting drugs during the trial. Despite the study’s limitations, it supports the efficacy of the intervention among injection drug users in China and provides evidence for potential benefits of expanding the program.

Program at a Glance

Goal: To reduce the spread of HIV/AIDS and HCV among IDUs by making sterile needles and syringes widely available to IDUs and promoting their use through needle social marketing

Target Populations: Injection drug users in China, typically men between the ages of 15 and 29

Geographic Location and Region: Guangxi and Guangdong provinces in China

Establishment and Duration: The intervention began in September 2002; China began scaling up needle exchange programs in 2006, and needle social marketing programs were still in effect at the time of this publication.

Resources Required and Goods and Services Provided: Educational pamphlets, posters, photos, videos, and lessons about drug abuse and HIV/AIDS and HCV; health workers and peer educators to provide counseling and mentoring in clinics and the community; clean needles and syringes to distribute

Strategies and Components

  • Utilized social marketing techniques to educate IDUs about HIV/AIDS and HCV risk

  • Targeted IDUs through needle-exchange programs

  • Increased availability of new needles and syringes

Key Partners: The Chinese Ministry of Health; the World AIDS Foundation funded the trial

Key Evaluation Findings

Statistically Significant

  • Reduced needle sharing

  • Increased condom use

  • Decreased HCV incidence among new injectors

  • Decreased overall HCV incidence rate in Guangdong

  • Decreased HIV incidence

No Effect

  • No change in the number of needle sharing partners

  • No change in the percent of IDUs sharing water

  • No significant change in overall HCV infection rate in Guangxi

Program Information and Implementation

Background, History, and Public Health Relevance

Researchers estimated that approximately 288,000 IDUs in China were infected with HIV by 2005, accounting for 44.3 % of all HIV infections nationwide. Needle sharing among China’s IDUs was a common practice, and reports estimated that 50–70 % of drug injections were with shared needles and syringes. The risk of IDUs acquiring HIV was acute, as Chinese drug users were more likely to engage in pre- and extramarital sex than those not using drugs and many female drug users exchanged sex for drugs or money.

Harm reduction programs, either needle-exchange or methadone maintenance programs, combined with health education and promotion activities, have demonstrated some effectiveness in reducing HIV transmission among IDU populations. Yet the Chinese government and population historically has viewed harm reduction programs as assisting drug users and promoting the use of prohibited drugs, and therefore such programs were illegal. However, health education, the only HIV prevention option available targeting IDUs, was ineffective in reducing HIV transmission among Chinese IDUs. China began focusing on needle social marketing, a harm reduction strategy that promotes the use of new needles and syringes to IDU social networks to discourage the practice of sharing used needles and syringes. As it wasn’t known how effective the strategy would be for reducing HIV transmission among IDUs in China, a community intervention trial was conducted to evaluate the efficacy of needle social marketing.

Theoretical Basis

The needle social marketing strategy was grounded in the principles of harm reduction, which focus on reducing the negative effects from unsafe behaviors rather than reducing the occurrence of unsafe behaviors.

Objectives

The strategy aimed to reduce the spread of HIV and HCV among IDUs through needle social marketing. It promoted the use of new needles and syringes and discouraged the use of shared injection equipment by making new needles and syringes widely available to IDUs.

Class and Type of Outcome or Behavior Change Targeted

  • ☑ Decrease IDU risk

  • ☐ Decrease noncommercial sex risk

  • ☐ Decrease commercial sex risk

  • ☐ Increase health services utilization (exams, testing, and treatment)

Target Population and Venue for HIV Prevention

The needle social marketing strategies targeted IDUs in the Chinese provinces of Guangdong and Guangxi who were typically men between the ages of 15 and 29. Intervention activities occurred in detoxification centers and in the wider community.

Pathways for Structural Change

  • ☑ Changes in programs

  • ☑ Changes in practices

  • ☑ Changes in policies and laws

The needle social marketing strategy promoted changes in programs to increase the availability, accessibility, and acceptability of new needles and syringes to IDUs and to direct the activities of peer educators. In addition, changes in practices encouraged detoxification centers and other community organizations to accommodate intervention activities such as health education.

Strategies and Tactics for Structural Change

HIV was first discovered in China in 1985, and the Chinese government dictated the country’s response to the growing epidemic. For over a decade, harm reduction strategies were not promoted for fear that they would be viewed as promoting illegal drug use. HIV transmission from prostitution and injection drug use contributed substantially to the growing epidemic. Changes in policies related to government prohibitions of needle exchange and other harm reduction strategies were critical components of a needle social marketing strategy. In 1997, the Chinese Academy of Preventive Medicine organized a conference and included international AIDS organizations in a discussion of how to target high-risk groups in China. As a result, governmental agencies in China began to realize the potential benefits of new evidence-based prevention strategies. Strategic documents such as the Medium- and Long-Term Strategic Plan for HIV/AIDS (1998–2010) defined the framework for a new Chinese response to the HIV epidemic.

A needle social marketing strategy emerged as a way for China to emphasize the positive aspects of needle exchanges and health education. Beginning in 2001, the State Council officially promoted needle social marketing as an HIV prevention strategy, due to evidence from needle-exchange programs in other countries. The Ministry of Health with the World AIDS Foundation helped to support an intervention in China, which eventually contributed to new national policy guidelines about needle-exchange programs in China and a scale-up of programs across the country.

Core Components

  • Political and governmental support of program activities

  • Peer education activities in the community targeting IDUs

  • Community support for program activities

  • Education of IDUs through one-on-one lessons and educational materials

  • Needle exchange

Resources Required

Educational pamphlets, posters, photos, videos, and lessons about drug abuse and HIV/AIDS; health workers and peer educators to provide counseling and mentoring in clinics and the community; and clean needles and syringes to distribute

Management Structure

Not reported

Implementation Themes

With the support of new government policies emphasizing the benefit of harm reduction strategies to curb the spread of HIV among target groups, the Chinese Ministry of Health and the World AIDS Foundation designed a needle social marketing strategy for Guangxi and Guangdong provinces that was amendable to health and police officials.

The program implementers conducted the needle social marketing in detoxification centers and in the wider community. In detoxification centers, health workers handed out educational pamphlets, displayed educational posters, delivered lessons about drug abuse and HIV/AIDS, and showed photo exhibitions and educational videos.

The intervention program also used local resources such as pharmacies, hospitals, and clinics to reach IDUs in the community. Intervention staff handed out educational pamphlets and hung educational posters, facilitated face-to-face health education sessions between heath workers and drug users, facilitated peer education, and dispensed and recalled needles and syringes. Health workers visited drug users’ homes or gathering places. Local hospitals and detoxification centers dispensed clean needles and injection drug materials. Peer educators also visited IDUs’ homes and places where they gathered to distribute clean needles and syringes—usually between three and ten needles at a time.

Main Challenges Faced

The researchers originally designed a longitudinal study, intending to recruit IDUs at the beginning of the study and to follow-up with them a year later. They gave IDUs an identification card at baseline and a card that promised them 30 Chinese yuan if they returned for a follow-up interview in a year. However, the researchers successfully followed up with only 12.4 % (102 participants) a year later, and more than half of them (60 participants) had lost their ID cards so their records could not be linked to the original baseline records. Because of the low follow-up rate, the researchers implemented a cross-sectional design and surveyed a new set of 750 drug users for the follow-up survey.

Program Continuity and Present-Day Status

The benefits of needle-exchange programs and needle social marketing revealed by the evaluation led the Ministry of Health to develop national guidelines on needle exchange, including the Regulations for the Prevention and Treatment of AIDS (March 2006) and the Action Plan for Reducing and Preventing the Spread of HIV/AIDS (2006–2010). Needle-exchange programs have expanded from 93 sites to 729 sites since 2006, with emphasis on rural areas. The original needle social marketing strategy has evolved since its initial implementation and the strategies are still in use in China at the time of this publication. They are often combined with additional services to IDUs, such as HIV counseling and testing, antiretroviral therapy, and condom distribution.

Other Locations and Regions that Have Implemented Similar Programs

  • The needle and syringe-exchange program of the Western Australia AIDS Council provided free or low-cost drug injection equipment to IDUs in addition to disposing safely of used injection equipment. The program also provided other services to IDUs, including advice, information, and referral services. The Australian government estimated that 25,000 HIV infections had been prevented in 2002 through needle and syringe programs in the country.

http://www.waaids.com/

  • STOP AIDS was established in Switzerland in 1987 by the Swiss AIDS Foundation and the Swiss Federal Office for Public Health. It began as a national, multimedia campaign targeting gay men to promote condom use, but has expanded to include information about injection drug use, needle sharing, and the spread of HIV.

Original Program Evaluation

Study Design

Timeline and Duration

The intervention began in September 2002 in Dagou (Guangdong Province) and in Luzhai (Guangxi Zhuang Autonomous Region) in November 2002. Baseline assessments in both regions were conducted in September 2002, and final assessments were conducted in June 2003 in Guangdong and in July 2003 in Guangxi.

Cohorts
  • ☑ Cross-sectional (snap shots in time)

  • ☐ Longitudinal (same people followed over time)

Temporal Direction of Data Collection Relative to Intervention
  • ☑ Prospective

  • ☐ Retrospective

Researchers collected data prospectively; however, the data were based on subject recall of behavior in the last month, 3 months, or 6 months and may be considered retrospective in that regard.

Assessment Time Points (Temporal Comparison)
  • ☑ Before and after intervention (baseline and follow-up measures)

  • ☐ After only

  • ☐ Serial (more than two measures taken over time)

Implementation Level (Geographic Comparison)
  • ☐ Countries

  • ☑ Regions (state level)

  • ☐ Counties

  • ☐ Cities

  • ☐ Towns

  • ☐ Villages

  • ☐ Households

  • ☐ Couples, pairs, and dyads

  • ☐ Individuals

Sampling Unit
  • ☐ Countries

  • ☐ Regions

  • ☐ Counties

  • ☐ Cities

  • ☐ Towns

  • ☐ Villages

  • ☐ Households

  • ☐ Couples, pairs, and dyads

  • ☑ Individuals

Recruitment Techniques

Researchers recruited IDUs from detoxification centers (if they had injected in the last 3 months) and in the community through key informants, peer educators, and mailings.

Randomization
  • ☐ No

  • ☑ Yes

    • ☑ Random assignment

    • ☐ Random sampling

Once potential counties were identified for the intervention in Guangdong and Guangxi, two counties in each province were randomly assigned to the intervention or control condition. Sampling was not random and was opportunistic.

Study Type

Quasi-experimental

Methods

Data Collection
Data Sources
  • ☑ Questionnaire or survey

  • ☐ Chart information or surveillance

  • ☑ Record of biological specimen (e.g., urine sample)

Interview
  • ☐ Interviewer administered

  • ☐ Self-administered

  • ☑ Unknown

Instruments
  • ☐ Paper and pencil (data entry after fieldwork)

  • ☐ Computer (ACASI or direct data entry in the field)

  • ☑ Unknown

Modality
  • ☑ In-person

  • ☐ Mail

  • ☐ Phone

  • ☐ Internet

Data Analysis

Exposure Variables Measured

Self-reported exposure to components of the intervention program (received needles, exposed to peer outreach, saw educational posters or pamphlets, participated in face-to-face counseling session)

Predictor Variables Measured

Control versus intervention communities

Outcome Variables Measured
  • ☐ Knowledge, attitudes, and beliefs

  • ☑ Behaviors and practices

  • ☑ Biomarker and clinical data

  1. 1.

    Change in high-risk drug use and sexual behaviors—the number of IDUs who had shared needles in the previous month, the number of needle sharing partners, and consistent condom use

  2. 2.

    Change in HIV prevalence and incidence

  3. 3.

    Change in HCV prevalence and incidence

Other Variables Measured
  • ☑ Demographics

  • ☐ Risk groups

  • ☐ Behaviors

Statistical Methods

The researchers compared categorical variables between intervention and control groups at baseline and follow-up with chi-squared tests and continuous variables with t-tests using SAS version 8.12. They calculated HIV and HCV incidences based on a subset of a retrospective cohort of drug injectors who initiated injection after the intervention began.

Strengths and Weaknesses of the Study Design and Methodology
  • ☐ Cross contamination between intervention and comparison groups

  • ☐ Concurrent interventions occurring in experimental and comparison areas

  • ☐ Historical bias or trend due to historical factors

  • ☑ Other

Originally meant to be a longitudinal study in which a group of IDUs were followed for the length of the trial, logistical barriers prevented the researchers from being able to implement that study design. Few baseline participants were successfully recruited for the follow-up study, so staff had to sample other IDUs opportunistically for the final survey.

The control and intervention arms were not comparable on measures of demographic variables and key outcome measures at baseline, meaning that intervention effects may have been hidden or exaggerated in some samples. It was not possible for the researchers to match communities on key outcome measures as it was difficult to find communities willing to implement the controversial program.

Results

Sample Size
 

Baseline

Follow-up

Guangdong

Intervention

235

226

Control

193

204

Guangxi

Intervention

194

219

Control

201

203

A total of 823 DUs participated in the baseline survey, but only 102 returned for a follow-up visit. Of these, only 42 could be linked to their records because the rest had lost their ID cards, so the researchers switched to a cross-sectional study design. An additional 750 IDUs were recruited for the follow-up survey bringing the total to 852.

Retention and Loss to Follow-Up (Cohort Studies Only)

Not applicable to the cross-sectional study

Sample Demographics
Age

Baseline

 

Guangdong

Guangxi

 

Intervention

Control

Intervention

Control

11–19

 3

 6

 1

 5

20–29

107

110

124

135

30–39

107

 68

 65

 55

40+

 18

 9

 4

 6

Follow-up

 

Guangdong

Guangxi

 

Intervention

Control

Intervention

Control

11–19

 1

12

 13

 19

20–29

 94

95

112

142

30–39

111

68

 85

 37

3740+

 20

15

 6

 4

Race or Ethnicity

Baseline

 

Guangdong

Guangxi

 

Intervention

Control

Intervention

Control

Han

235

192

134

 45

Zhuang

 0

 1

 58

152

Other

 0

 0

 2

 4

Follow-up

 

Guangdong

Guangxi

 

Intervention

Control

Intervention

Control

Han

224

204

152

 18

Zhuang

 2

 0

 62

184

Other

 0

 0

 4

 0

Gender

Baseline

 

Guangdong

Guangxi

 

Intervention

Control

Intervention

Control

Male

234

182

178

200

Female

 1

 11

 16

 1

Follow-up

 

Guangdong

Guangxi

 

Intervention

Control

Intervention

Control

Male

221

190

194

197

Female

 5

 14

 25

 6

Sexual Orientation

Not reported

Outcome and Other Measures

Measure

Finding

Needle distribution and collection

In Dagou (Guangdong Province), 47,000 syringes were dispensed and 24,780 were returned (53 % return rate). In Luzhai (Guangxi), 57,209 syringes were dispensed and 52,930 were returned (92 % return rate)

Exposure to intervention

69.5 % of IDUs in Guangdong and 46.8 % in Guangxi reported receiving needles from the intervention program. Many IDUs in Guangxi participated in a face-to-face counseling session with a health worker (52.7 %) or peer educator (55.2 %), and the figures were similar for Guangdong (61.7 % and 66.0 %, respectively)

Change in high-risk drug use and sexual behaviors

In both Guangdong and Guangxi, baseline numbers of needles shared in the past month were similar for the intervention and control groups. At follow-up, the number of needles shared in the past month was significantly less for the intervention communities than the control communities (p < 0.0001 in Guangdong and p < 0.009 in Guangxi). The number of IDUs who reported always using a condom in the final survey was higher in the intervention community in both provinces, but only statistically significant in Guangdong (p = 0.015)

Change in HIV incidence

The HIV infection rate decreased in the intervention communities—by 6.4 % in Dagou (p = 0.16) and 3 % in Luzhai (p = 0.54). Among individuals who started injecting during the trial, there were fewer individuals with HIV in the intervention communities than in the control communities (p = 0.011 in Guangdong and p = 0.285 in Guangxi)

Change in HCV incidence

Among individuals who started injecting during the program, the HCV incidence rate was 51 % in the intervention communities and 83.6 % in the control communities

 

(p < 0.001). The lower incidence in the intervention communities was significant in both Guangdong (p = 0.001) and Guangxi (p < 0.014)

Conclusions

The study demonstrated that needle social marketing effectively reduced some risky injection and sexual practices (i.e., needle sharing, not using a condom) and may have reduced the incidence of HIV and HCV infection among Chinese IDUs. In addition, needle social marketing markedly reduced HIV and HCV infection rates among IDUs who began injecting drugs during the trial. Despite the methodological problems the researchers encountered during the study, it provided evidence in support of needle social marketing programs.

Implications and Lessons Learned

The results of the evaluation demonstrated the feasibility of needle social marketing strategies in reducing HIV and HCV risky behaviors among IDUs in China and significantly contributed to China’s confidence in and support of future needle-exchange programs. Needle exchange was included among the strategies outlined in the Regulations for the Prevention and Treatment of AIDS, issued in March 2006. Needle exchange was also included in China’s Action Plan for Reducing and Preventing the Spread of HIV/AIDS (2006–2010). China has been increasing needle-exchange programs since 2006.

Supplementary Materials Available

The integration of multiple HIV/AIDS projects into a coordinated national programme in China

Case Study 5: The Vietnam and China Cross-Border Project: Effect on HIV Risk Behaviors of Injection Drug Users

Original Program Developers and Evaluators

Theodore M.Hammett

Ryan Kling

Patrick Johnston

Wei Liu

Doan Ngu

Patricia Friedmann

Kieu Thanh Binh

Ha Viet Dong

Ly Kieu Van

Meng Donghua

Yi Chen

Don C.Des Jarlais

Case Study Contents

  • Abstract

  • Program at a Glance

  • Program Information and Implementation

  • Original Program Evaluation

  • Implications and Lessons Learned

  • Supplementary Materials Available

Bibliography

Des Jarlais, D. C., Kling, R., Hammett, T. M., Ngu, D., Liu, W., Chen, Y., et al. (2007). Reducing HIV infection among new injecting drug users in the China-Vietnam Cross Border Project. AIDS, 21(suppl 8), S109–S114.

Hammett, T. M., Kling, R., Johnston, P., Liu, W., Ngu, D., Friedmann, P., Binh, K. T., et al. (2006). Patterns of HIV prevalence and HIV risk behaviors among injection drug users prior to and 24 months following implementation of cross-border HIV prevention interventions in Northern Vietnam and Southern China. AIDS Education and Prevention, 18(2), 97–115.

Abstract

To target injection drug users (IDUs) on both sides of an international border, along a well-known heroin transshipment route, the Cross-Border Project implemented an HIV prevention project in five sites in Vietnam and four sites in China. In these intervention sites along the border, peer educators worked to reach IDUs in the community on a regular basis. Peer educators provided IDUs with information on HIV risk reduction and distributed needles and syringes, distilled water for injection, and condoms. Peer educators also collected used and discarded injection equipment and disposed of these materials properly to reduce the public health risk. Eventually, funding was obtained to expand the intervention to target women at risk (commercial sex workers [CSWs] and sexual partners of IDUs) in light of emerging evidence that the HIV epidemic in the region was moving into the general population. This was the first cross-border HIV prevention project targeting IDUs in which the same interventions were implemented on both sides of an international border. In both Lang Son and Ning Ming, there was significant improvement on all of the drug-related risk behaviors of IDUs. In addition, HIV prevalence and estimated incidence fell by approximately half at the 24-month survey and by approximately three-quarters at the 36-month survey in both areas.

Program at a Glance

Goal: To reduce HIV risk behaviors among IDUs in order to stabilize HIV prevalence and reduce HIV incidence on both sides of an international border and to prevent cross-border HIV transmission

Target Populations: The project first targeted IDUs and expanded to include women at risk.

Geographic Location and Region: The intervention was implemented in five sites in Lang Son Province, Vietnam, and four sites in the Ning Ming County, Guangxi Province, China.

Establishment and Duration: Program implementation began in July 2002 in Lang Son and in October 2002 in Ning Ming. The 4-year intervention concluded in 2006.

Resources Required and Goods and Services Provided: Brochures for peer educators on reducing HIV risks from drug use and sexual activities, new needles and syringes, sterile injection water, condoms, and pharmacy vouchers for peer educators to distribute. Over the course of the project, 10,000–12,000 new needles and syringes were provided in each country to IDUs. Funding supported mass media messages on billboards, radio, and television ads and the salaries of peer educators. In the original intervention, peer educators received monthly stipends based on the acceptance of their weekly reports. In Lang Son, the monthly stipend was about $30, and in Ning Ming, peer educators received a stipend of $117 per month, while in Ha Giang it was $46.

Strategies and Components

  • Utilized a peer education model and elements of social marketing

  • Incorporated risk-reduction practices into IDU education and resource provision

  • Implemented across the border of two countries that were heavily affected by injection drug-use HIV transmission

Key Partners: The Ford Foundation; the U.S. National Institute on Drug Abuse (NIDA); Global Fund to Fight AIDS, Tuberculosis and Malaria; the United Kingdom Department for International Development; and an anonymous donor in New York City. The members of the project team were Abt Associates, Inc.; Beth Israel Medical Center; Lang Son Provincial Health Services, Provincial HIV/AIDS Center; Ha Giang Provincial Health Services; Guangxi Center for HIV/AIDS Prevention and Control, Guangxi CDC; and Ning Ming County Health Department.

Key Evaluation Findings

Statistically Significant

  • Decreased sharing of needles and syringes, drug solution, and other injection equipment

  • Decreased percent of IDUs from across the border (Vietnam to China) injecting drugs

  • Decreased HIV prevalence (Vietnam only)

No Effect

  • Did not decrease sex-related HIV risk behaviors

  • Did not significantly decrease the frequency per month of buying drugs across the border

  • Did not significantly decrease the percent of IDUs from across the border (China to Vietnam) injecting drugs

  • Did not significantly decrease HIV prevalence in China

Program Information and Implementation

Background, History, and Public Health Relevance

Injection drug users who share with other IDUs injection needles, syringes, and other injection equipment are at great risk of becoming infected with HIV, as the prevalence of HIV among IDUs in developing countries has been found be as high as 40–90 %. Along the heroin transshipment route that includes northern Vietnam and southern China, the majority of IDUs are poor and thus more likely to share needles and syringes. Many IDUs become infected with HIV and then infect their sexual partners, causing the virus to spread into the general population. In areas of southern China and northern Vietnam, an estimated 70 % of people with HIV were infected through needle-related behavior. Vietnam is estimated to have about 150,000 IDUs total, with an overall HIV prevalence among IDUs of about 32 % and as high as 75 % in some northern parts of the country. China has at least two million IDUs, with an overall HIV prevalence of about 12 % and a prevalence as high as 75 % in some areas.

The drug trade traffic across the border between dealers and users contributes to the flourishing HIV epidemic along the northern Vietnam and southern China border. The essentially open border, which many people cross on a daily basis for both legitimate and illegal reasons, makes it difficult to monitor, control, and prevent the spread of HIV in either country without intervention in the other. Understanding of HIV transmission across international borders is particularly important, and few HIV prevention programs have been coordinated in such a manner.

Theoretical Basis

The project was based on a behavioral-ecological model, providing a way to conceptualize structural interventions that operate at multiple levels in communities. This model integrates learning theories that focus on individual behaviors with ecological influences at social, cultural, community, and local levels.

Objectives

The specific aims of the project were to:

  1. 1.

    Show control of HIV transmission on both sides of the border through stable HIV prevalence rates among IDUs

  2. 2.

    Show control of HIV transmission on both sides of the border by low HIV incidence (targeting 1/100 person-years at risk) among IDUs

  3. 3.

    Show very large reductions in HIV injection risk behavior, from the estimated 60 % of IDUs engaging in receptive sharing of needles and syringes to a stable level of 30 %

  4. 4.

    Show large reductions in HIV transmission behavior, from the estimated 60 % of IDUs engaging in distributive sharing to a stable level of 30 %

  5. 5.

    Show statistically significant reductions in unsafe sexual behavior among IDUs

  6. 6.

    Demonstrate very large-scale safe disposal of used injection equipment, with a target safe disposal of 150,000 used syringes per year

  7. 7.

    Achieve significant increases in HIV knowledge and in expressed support for the project interventions among samples of residents in the target communities

The intervention also sought to improve cross-border collaboration and in-country capacity for prevention interventions, positive policy development, and behavioral and epidemiological research.

Class and Type of Outcome or Behavior Change Targeted

  • ☑ Decrease IDU risk

  • ☑ Decrease noncommercial sex risk

  • ☑ Decrease commercial sex risk

  • ☐ Increase health services utilization (exams, testing, and treatment)

Target Population and Venue for HIV Prevention

The project targeted IDUs on both sides of the border between Lang Son Province in northern Vietnam and Guangxi Province in southern China. The program also expanded to include women at risk (such as CSWs and sex partners of IDUs).

Pathways for Structural Change

  • ☑ Changes in programs

  • ☑ Changes in practices

  • ☑ Changes in policies and laws

The intervention operated through changes to (1) programs (by increasing the availability and accessibility of drug injection equipment and condoms to IDUs), (2) practices of peer educators (who disseminated information about safer behaviors and performed needle exchanges), and (3) policies through peer educator engagement with local governmental bodies.

Strategies and Tactics for Structural Change

Implementation of the Cross-Border Project began in July 2002 in Lang Son Province, Vietnam, and in October 2002 in Ning Ming County, Guangxi Province, China. Trained peer educators regularly contacted other IDUs in the communities and provided them with information on reducing drug use and sexual risk behaviors. They distributed sterile needles and syringes, ampoules of sterile water for injection, condoms, and no-cost vouchers that could be redeemed for sterile injection equipment and condoms in participating local pharmacies. Over the course of the new project, an average of 10,000–15,000 new needles and syringes were provided per month in each country. The peer educators also collected and safely disposed of used needles and syringes directly from drug injectors at injecting sites in the communities. Project staff also worked with law enforcement and various community members to create understanding of and support for the project.

The initial groups of peer educator recruits received training from the Centre for Harm Reduction of the McFarlane Burnet Institute in Melbourne, Australia. The training content included:

  • Basic information on HIV/AIDS and HIV transmission routes

  • Extensive coverage, including role-plays and other exercises, of strategies for preventing HIV transmission and acquisition both with regard to drug injection and sexual behaviors

  • Sessions on reaching and contacting IDUs in the community, conveying HIV risk-reduction information, and answering participants’ questions about HIV and risk factors

  • Information regarding peer educators as representatives of the project and ways that they could help gain and maintain support for the project in the general community, explaining the true objectives of the interventions and seeking to counter misinformation and misunderstanding

After the initial training, the local health departments provided ongoing training for the peer educators as well as initial training for new peer educators joining the project. Periodic refresher training sessions were held, and the peer educators’ weekly meetings often included training on special topics such as overdose prevention and strategies for reaching women IDUs.

The health departments selected the peer educators based on their performance during the initial training and assurances that their families would support their work with the project. Most of the peer educators were young men, but in each country several women were recruited in an effort to reach women IDUs and CSWs in the communities. The peer educators were supervised locally by health department staff. For a variety of reasons, mostly but not exclusively associated with the peer educators’ ongoing drug use, there was substantial turnover among them. Local health department staff recruited and trained replacements as needed.

Core Components

The intervention components for the Cross-Border Project included:

  1. 1.

    Peer-based education of IDUs

  2. 2.

    Regular contact with IDUs in the community to provide information on reducing drug-use-related and sexual HIV risks, orally and through distribution of brochures

  3. 3.

    Social marketing, including pharmacy and clinic vouchers (China and Vietnam), direct exchange (Vietnam), peer educators distributing new injection equipment, and condoms and vouchers redeemable for those items in participating pharmacies

  4. 4.

    Public health infection control through peer educators collecting and disposing of used needles and syringes

  5. 5.

    Community education, including regular meetings and community workshops, and letters of support from police and other agencies

  6. 6.

    Job training for peer educators

  7. 7.

    Support for drug-use cessation

  8. 8.

    Cross-border collaboration

Resources Required

The program required brochures on reducing drug-use-related and sexual HIV risks for peer educators to distribute, new needles and syringes, sterile injection water, condoms, and pharmacy vouchers for peer educators to distribute. Over the course of the project, 10,000–12,000 new needles and syringes were provided in each country to IDUs. Funding supported mass media messages on billboards, radio, and television ads and the salaries of peer educators.

Management Structure

In Vietnam, the National AIDS Standing Bureau (part of the Ministry of Health) initially provided central-level leadership and technical oversight. Later, the Lang Son and Ha Giang Provincial Health Departments provided the leadership, with technical support from central-level consultants who traveled to sites regularly to provide technical oversight and support. In China, the central-level leadership was always situated at the provincial level, with little or no involvement of national agencies.

At the local level, the project director was the leader of the local health department and was in charge of project implementation and coordination with police and other relevant agencies. The project manager oversaw and managed the project work to ensure it complied with local rules and regulations and the project design. The community-level team leader provided oversight for the day-to-day work of peer educators.

Implementation Themes

The idea for the Cross-Border Project evolved during a Ford Foundation-sponsored workshop on HIV prevention for IDUs in Kunming, China, in September of 1997. It took 4 years for researchers from the USA, China, and Vietnam to develop the necessary partnerships and secure funding for the project. Funding was partially from the Ford Foundation offices in Beijing, China, and Hanoi, Vietnam, through grants to the Guangxi Center for HIV/AIDS Prevention and Control and Vietnam’s National AIDS Standing Bureau. Funding from the National Institute on Drug Abuse, through a grant to Abt Associates Inc., provided initial support for the project in 2001.

Main Challenges Faced

In Vietnam and China, drug use was seen as a social evil. Drug users and people living with HIV were highly stigmatized and suffered from serious discrimination. Drug users were often sent to compulsory detoxification labor camps in China or rehabilitation centers in Vietnam. The behavior of law enforcement officials had a crucial impact on the success of the cross-border interventions. For example, individual police crackdowns on drug users caused reductions in IDU participation.

Misinformation and misunderstanding were seemingly endemic. At 18 months, one-third of Chinese respondents did not believe that the interventions would reduce the numbers of used needles and syringes littering the communities, and more than 30 % of community respondents in China and 18 % in Vietnam continued to believe the interventions would increase drug use.

Most peer educators were active drug users and many were HIV positive, and problems such as mobility, misbehavior, arrest, illness, and death arose. It was necessary for local project staff to keep a close eye on the activities of peer educators.

In Ning Ming, the pharmacy vouchers were initially popular among the IDU population, but after a few months IDUs stopped using them and the developers eventually discontinued this aspect of the intervention. They speculated that their drop in popularity was because there was little incentive for pharmacies to participate in the program.

Program Continuity and Present-Day Status

Program implementation began in July 2002 in Lang Son and in October 2002 in Ning Ming. The Cross-Border Project has been in continuous existence since then and has added additional sites in Ha Giang Province, Vietnam, and Guigang City, Guangxi.

Other Locations and Regions that Have Implemented Similar Programs

The Cross-Border Project was the first of its kind to target populations across country borders. Since the project proved its success with IDU populations in Vietnam and China, other similar cross-border projects have been established. One example is the HIV/AIDS Asia Regional Program (HAARP) Cross-Border Project for the Yunnan Provincial HIV/AIDS Prevention and Control Bureau (YNAB), located in an area of southwest China that shares a border with Myanmar, Laos, and Vietnam.

Original Program Evaluation

Study Design

Timeline and Duration

Researchers in the USA, Vietnam, and China began planning the project in 1997 and worked for the next 4 years to complete the plan and secure funding for the project. Full implementation of the program began in Vietnam (Lang Son sites) in July 2002 and in China (Ning Ming sites) in October 2002. After baseline surveys were conducted in 2002, assessments were also conducted at 6, 12, 18, 24, 36, and 48 months post-baseline. Findings from the first 24 months of the project are reported here.

Cohorts
  • ☑ Cross-sectional (snap shots in time)

  • ☐ Longitudinal (same people followed over time)

Cross-sectional surveys were conducted at baseline (before any implementation), 6 months (while the project was still in start-up), 12 months (by which time the project had reached full implementation), 18 months, 24 months, 36 months, and 48 months post-baseline. Individual subjects were permitted to participate in multiple survey waves.

Temporal Direction of Data Collection Relative to Intervention
  • ☑ Prospective

  • ☐ Retrospective

Assessment Time Points (Temporal Comparison)
  • ☐ Before and after intervention (baseline and follow-up measures)

  • ☐ After only

  • ☑ Serial (more than two measures taken over time)

Implementation Level (Geographic Comparison)
  • ☐ Countries

  • ☐ Regions

  • ☑ Counties

  • ☐ Cities

  • ☐ Towns

  • ☐ Villages

  • ☐ Households

  • ☐ Couples, pairs, and dyads

  • ☐ Individuals

Sampling Unit
  • ☐ Countries

  • ☐ Regions

  • ☐ Counties

  • ☐ Cities

  • ☐ Towns

  • ☐ Villages

  • ☐ Households

  • ☐ Couples, pairs, and dyads

  • ☑ Individuals

Recruitment Techniques

In Ning Ming County, China, researchers had project peer educators send letters to IDUs they knew personally, inviting them to participate in the project. The IDUs who came to project centers for interviews were encouraged to recruit two to three additional participants. The research participants received 20 Chinese yuan (approximately US $2.50) for the interview, 5 yuan for each additional male respondent recruited, and 10 yuan for each addition woman respondent recruited.

In Vietnam, approximately half of the sample was picked randomly using probability proportionate to size from lists of IDUs registered with the government. The other half was randomly recruited from IDUs present at drug-injecting sites mapped by the study team. The Vietnamese participants were paid 30,000 dong (approximately US $2.00) for participating.

Randomization
  • ☐ No

  • ☑ Yes

    • ☐ Random assignment

    • ☑ Random sampling

In studies of IDU populations, it is standard practice to treat targeted or snowball samples as if they were random samples because very rarely do detailed sampling frames exist for this population.

Study Type

Quasi-experimental

Methods

Data Collection
Data Sources
  • ☑ Questionnaire or survey

  • ☐ Chart information or surveillance

  • ☑ Record of biological specimen (HIV testing)

Interview
  • ☑ Interviewer administered

  • ☐ Self-administered

Instruments
  • ☐ Paper and pencil (data entry after fieldwork)

  • ☐ Computer (ACASI or direct data entry in the field)

  • ☑ Not reported

Modality
  • ☑ In-person

  • ☐ Mail

  • ☐ Phone

  • ☐ Internet

Data Analysis

Exposure Variables Measured

Exposure to the intervention was assessed based on self-reported measures of receiving aspects of the intervention. For example, across all of Ning Ming County sites, 82 % of 24-month survey participants said that they had received either new needles and syringes (directly) or pharmacy vouchers from the project in the last 6 months. In the Lang Son sites, 68 % reported receiving pharmacy vouchers for new needles and syringes.

Outcome Variables Measured
  • ☐ Knowledge, attitudes, and beliefs

  • ☑ Behaviors and practices

  • ☑ Biomarker and clinical data

In the cross-sectional surveys, participants were asked a series of questions about drug using and sexual risk behaviors for HIV and were tested for HIV. The prevalence of the behaviors and of the virus served as outcome indicators.

Other Variables Measured
  • ☑ Demographics

  • ☐ Risk groups

  • ☑ Behaviors

Standard demographic questions assessed gender and age, among other factors. At baseline a variety of predictors were measured and found to relate to the outcome variables of interest. Therefore, these variables (including border-crossing factors, HIV knowledge, and HIV status) were considered in the final statistical models.

Statistical Methods

The researchers provided descriptive statistics on the demographic characteristics, participation in the project interventions, risk behaviors, and HIV prevalence at all-time points. To estimate the change in outcomes over the five surveys, they used logistic models for binary outcomes and linear models for continuous outcomes. Both types of models were fit by the method of generalized estimating equations using the GENMOD procedure in SAS, with a robust estimate of the parameter variance matrix based on an independent working correlation matrix.

Strengths and Weaknesses of the Study Design and Methodology
  • ☐ Cross contamination between intervention and comparison groups

  • ☐ Concurrent interventions occurring in experimental and comparison areas

  • ☑ Historical bias or trend due to historical factors

  • ☑ No comparison or control sites

Results

Sample Size

Site

Baseline

6-month

12-month

18-month

24-month

Ning Ming

291

331

303

299

209

Lang Son

342

340

327

335

333

Retention and Loss to Follow-Up (Cohort Studies Only)

Not applicable to this study

Sample Demographics
Age

The average age of the participants was 28.5 years.

Race or Ethnicity

In Lang Son, Vietnam, 28–48 % of the participants reported being a member of a minority group. In Ning Ming, China, 68–78 % reported being a member of a minority group with variation by site and time point.

Gender

The participants were predominately male (88–100 %) depending on the site and time point assessed.

Sexual Orientation

Not reported

Outcome and Other Measures

Measure

Finding

Intervention coverage

Across all Ning Ming County sites, 82 % of 24-month survey participants said that they had received either new needles and syringes or pharmacy vouchers from the project in the last 6 months. Across Lang Son sites, 68 % reported receiving pharmacy vouchers from the project

Risk behaviors

All drug-related risk behaviors improved significantly in both Ning Ming and Lang Son over time with a statistical model controlling for site and repeated measurements

Ning Ming County

Baseline (%)

6-month (%)

12-month (%)

18-month (%)

24-month (%)

p-valuea

Receptive sharing of needles and syringes in the past 6 months

47

29

22

17

 9

<0.001

Distributive sharing of needles and syringes in past 6 months

52

25

27

17

11

<0.001

Shared drug solution in past 6 months

41

22

18

13

 8

<0.001

Shared other injection equipment in past 6 months

63

40

32

23

 9

<0.001

Shared any injection equipment in past 6 months

76

53

47

31

17

<0.001

Lang Son Province

Baseline (%)

6-month (%)

12-month (%)

18-month (%)

24-month (%)

p-valuea

Receptive sharing of needles and syringes in the past 6 months

 5

 5

 2

 3

 2

0.008

Distributive sharing of needles and syringes in past 6 months

 6

 5

 1

 4

 1

<0.001

Shared drug solution in past 6 months

32

39

25

32

16

<0.001

Shared other injection equipment in past 6 months

31

35

35

35

22

0.025

Shared any injection equipment in past 6 months

47

47

46

51

30

<0.001

HIV prevalence

HIV prevalence in the Lang Song sites declined from 46 % to 32 % between baseline and 24 months. In Ning Ming sites, HIV prevalence was stable: 16 % at baseline and 14 % at 24 months

 

Baseline (%)

6-month (%)

12-month (%)

18-month (%)

24-month (%)

p-valuea

Ning Ming

16

23

14

13

14

0.069

Lang Son

46

46

43

37

32

<0.001

  1. aAll p-values control for site and correlation between repeated measurements
Conclusions

The Cross-Border Project reached a significant percent of the IDU target population and was able to reduce drug-related risk behaviors and HIV prevalence, especially in Lang Son Province, Vietnam. The researchers concluded that the project reached approximately 65 % of IDUs in the Lang Son and Ning Ming sites and qualified as a high-coverage intervention, with demonstrated success in improving key outcomes.

Reducing the international spread of HIV among IDUs will require programs at the global, regional, national, and local cross-border levels with coordination on both sides of borders. Programs of sufficient scale will be needed that allow IDUs to readily obtain clean injection equipment on either side of a border.

Because the Cross-Border Project successfully gained the support of all stakeholders, it offered important lessons in terms of community outreach and the need for strong and ongoing educational efforts. The interventions are being replicated in another Vietnam-China border region (Quang Ninh-Guangxi) as well as in Uzbekistan. The ultimate success of such HIV prevention interventions for IDUs depends on full understanding and support in the communities where they are implemented. Intensive ongoing community education will help prevent misunderstanding of project interventions and stigmatization of IDUs.

Implications and Lessons Learned

The demonstrated success of the Cross-Border Project supports the implementation of similar programs in the future, the success of which, according to the original developers, will depend on the following advice:

Guidance About Peer Educators

The developers emphasized the importance of selecting appropriate peer educators systematically and with care to ensure that those chosen are enthusiastic, committed, and honest. Candidates should undergo a comprehensive training session before final selections are made. Before they begin work, they should be required to sign contracts that give details about duties, payment, and standards of conduct. The team leaders should provide initial and continuing training for peer educators that focus on the knowledge and skills necessary for implementation of the intervention and how to access the target population. When they do their work, peer educators should be given ID cards and uniforms to indicate their official status and help them avoid police interference. They should also be given appropriate safety equipment for handling and disposing of used needles and syringes. The number of peer educators chosen should be directly related to the size of the population the intervention wishes to target.

Ideal Traits of Local Program Staff

The local program staff are a critical component in the success of the intervention. If possible, program staff involved in the project should be enthusiastic, committed, and should stay with the program for the entire duration of the intervention. They should provide consistent supervision to the peer educators, and they should terminate the employment of those who sell drugs, commit crimes, or misuse project resources or supplies.

Selection of Pharmacies

The pharmacies that participate in the intervention should be those that are favored by IDUs and are easily accessible to them. Pharmacies should be replaced with an alternate if they deliberately misuse project supplies or resources.

Community Involvement

The developers stressed the importance of continually keeping the community informed of the project’s operations and activities, to help garner public support for the project. The developers advised that it is important to continually remind the community that the intervention does not encourage or facilitate increased drug use, especially if this is commonly believed. In addition, project staff should pass along information about HIV/AIDS to maintain community awareness and understanding and to collect feedback from the community and IDUs so the project can operate more effectively. Project staff should aim to keep the lines of communication open between the two countries—by conducting joint meetings—so that both countries can share their experiences and most effectively reach IDUs who cross the border.

Additional References

Abt Associates. A promising cross-border HIV prevention project for injection drug users. Abt Abstracts, 1(6).

Abt Associates (2004). Stopping HIV at the border: An innovative project targets drug users in China and Vietnam. International Perspectives, September 2004.

Des Jarlais, D. C., Johnston, P., Friedmann, P., Kling, R., Liu, W., Ngu, D., et al. (2005). Patterns of HIV prevalence among injection drug users in the cross-border area of Lang Son Province, Vietnam, and Ning Ming County, Guangxi Province, China. BMC Public Health Journal, 5(89).

Ford Foundation (2010). Cross-Border HIV prevention interventions for injection drug users and women at risk: Ning Ming County, Guangxi Province, China; Lang Son and Ha Giang Provinces Vietnam. Implementation Manual, March 2010. Supported by the Ford Foundation: Hanoi, New York, Beijing.

Hammett, T. M., Johnston, P., Kling, R., Liu, W., Ngu, D., Duy Tung, N., et al. (2005). Correlates of HIV status among injection drug users in a border region of southern China and northern Vietnam. Journal of Acquired Immune Deficiencies Syndrome, 38(2),228–235.

Hammett, T. M., Norton, G. D., Kling, R., Liu, W., Chen, Y., Ngu, D., et al. (2005). Community attitudes toward HIV prevention for injection drug users: Findings from a cross-border project in southern China and northern Vietnam. Journal of Urban Health, 82(4), 34–42.

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Golden, R., Collins, C., Cunningham, S., Newman, E., Card, J. (2013). Overview of Structural Interventions to Decrease Injection Drug-Use Risk. In: Best Evidence Structural Interventions for HIV Prevention. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7013-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7013-7_2

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7012-0

  • Online ISBN: 978-1-4614-7013-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics